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ABSTRACT 
 
 
 
 
THE HUMAN–HOOKWORM ASSEMBLAGE:  
CONTINGENCY AND THE PRACTICE OF HELMINTHIC THERAPY 
 
Through a qualitative analysis of the use of intestinal parasites for treating 
immune system disorders, this research illustrates how contingency emerges in 
the context of the human relationship to hookworms. The affect of the human–
nonhuman relationship is an important part of understanding the direction of 
evolutionary medicine today, and has implications for the politics of biological 
health innovations. The shift from the bad parasite to a parasite that at least 
sometimes heals, discursively and materially, has opened new spaces for patients 
to change the way they relate to medical knowledge, medical professionals, and 
pharmaceutical companies. Hookworms are banned by the FDA, which sets the 
scene for lively, but sometimes rebellious, hybridity between host and parasite. 
Underground and do-it-yourself hookworm therapy cultures have sprung up in 
around the site of the gut. I argue that not only is material hookworm affect as 
important as human discourses in negotiating the rapidly advancing field of 
biome reconstruction, but it also plays a role in how that biome reconstruction 
takes place, conventionally or otherwise.  
 
KEYWORDS: assemblage, contingency, health geography, helminthic therapy, 
microbiome 
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NOTES ON TERMINOLOGY 
 
I use the term “helminth” to denote parasitic worms that live in other animal 
hosts. I use “helminthic therapy” to denote a therapy that uses helminths as 
treatment rather than “helminth therapy,” which usually implies the emilination 
of a helminth infection.  
I use common names for specific helminth types. The three types that most 
helminthic therapy research focuses on are Necator americanus (one of two human 
hookworm varieties), Trichuris suis (pig whipworm), and Trichuris trichiura 
(human whipworm). In literature on helminthic therapy, the latter two are 
commonly appended with “ova” and called TSO and TTO, respectively. All three 
are in the Nematoda, or roundworm, phylum. 
The terms “hookworm” and “hookworms” are not interchangeable. 
“Hookworm” denotes an individual hookworm body, or else is used as a noun 
adjunct, as in “hookworm treatment.” “Hookworms” implies the multiplicity of 
hookworm affects that emerge throughout their relationships with other bodies, 
environments, institutions, and discourses.    
In an effort to be as honest as possible, I occasionally use the word “subjects” 
(not “participants”) to refer to the people I am studying, especially when I wish 
to include both interviewees and online helminth users. This project, like many 
other social science projects, still subjectifies the people it studies. While all 
research subjects are in some way participants, most scholarly research sets up a 
dichotomy between researcher and researched, creating uneven subjectivities 
that I wish to acknowledge. 
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CHAPTER ONE: INTRODUCTION 
 
Immune system disorders have risen sharply in recent years. This category of 
medical conditions includes autoimmune and inflammatory diseases, in which 
the body’s immune cells attack its own tissues, and allergic and asthmatic 
reactions, in which the immune system reacts to harmless substances as if they 
were pathogenic intruders. Immunosuppressant drugs are available, but the 
emerging method of biome restoration may prove both safer and more effective 
at treating immune system disorders (Parker et al. 2012). The etiology of this 
growing problem may partly be our modern, hyper-hygienic lives—we 
experience fewer deaths from infection today, but immune disorders may be the 
cost. Biome restoration is the idea that if we can tone down human hygiene in the 
right ways—perhaps through the addition of low-impact parasites—we can 
overcome some of these diseases.  
Helminthic (parasite) therapy is a non-traditional medical treatment that uses 
hookworms and other intestinal parasites that are, elsewhere, considered a 
devastating health problem, as a form of biome restoration, in the hope of 
modulating the immune system for those with chronic immune disorders. This 
study focuses on the use of hookworms to treat Crohn’s disease, an immune 
disorder of the lower digestive tract. The presence of hookworms in a Crohn’s 
patient often calms the extreme inflammation associated with the disease. 
Hookworms are set apart from other parasites in that they are not contagious on 
contact and reproduce in soil, not the human body. Further, their pathology is 
often minimal or nonexistent.  
Once helminths were recognized by patients and entrepreneurs as valuable 
treatment, the FDA stepped in, classifying them as biological drugs, and 
effectively banning their sales and distribution. It was only 100 years ago that 
they were endemic in the US South, and considered a setback to US economic 
and social development. Today, patients face not just anti-helminth laws, but 
also a hefty price tag—about $3,000 plus a plane ticket overseas—and a strong 
“yuck” factor. Despite these concerns, perhaps thousands of individuals in the 
US have managed to obtain the worms, seeking them overseas, or else producing 
them for self, friends, and family from their own supplies. 
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I will use three convergent concepts—assemblage, affect, and materiality—to 
explore the medicalized human–helminth relationship. Each concept builds off 
the other two, and they often appear together in recent geography literature (H. 
Lorimer 2008; J. Lorimer 2007; Whatmore and Hinchliffe 2010; Braun 2008; 
Bingham and Hinchliffe 2008; McCormack 2007; Greenhough 2012). An 
assemblage is a grouping of interconnected elements that emphasizes the 
relations between the elements rather than the elements themselves.  
No assemblage functions by the agency of individually articulated elements. 
Rather, material outcomes arise from the relationships between various elements 
making up the assemblage. In this case, I will be exploring an assemblage 
centered around humans and hookworms, but it also includes the FDA, doctors, 
pharmaceutical companies and pharmaceuticals, and the chemical interactions 
between animal bodies. Affect can be described as the forces that move along 
these relationship lines. It is a response, event, or action stripped of its 
representational qualities, and instead pertains to the material relationship 
between two elements. Finally, I emphasize materiality because of the limits of 
exploring the human–hookworm relationship from a purely constructivist 
perspective. A purely constructivist account of the human–hookworm 
relationship, one in which people’s reactions to hookworms become predictable 
based on social representations of them, creates a static reality in which only 
humans with the power to write the script may play a causative role, while a 
world full of the contingency of emerging performances and affective 
relationships (Stallins 2012; Barad 2003) implies that any given party, human or 
non-human, can shape an outcome. In this case, assemblage can account for how 
patients with autoimmune disease may take the reigns in health practice with the 
knowledge that medical science is not written in stone, or even written at all. 
My thesis addresses two questions relevant to autoimmune disease in today’s 
changing world. First, how do humans learn to be affected by hookworms? In 
addition to establishing that affect exists in the human–hookworm relationship, I 
explain how that affect unfolds, using the concept of learning to be affected. I 
review how this relationship produces material results, including differences 
within a single species—as in how hookworms sometimes render people sick, 
and other times render them well.  
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Second, which aspects of hookworm therapy aid incorporation into 
institutional medicine, and which hinder incorporation? I pose this question in 
order to explore the multifarious directions that relationships with hookworms—
or more generally, any given human–non-human relationship—can take. I 
explore ways that hookworms in particular interact with institutional medical 
operations, in some ways augmenting them and in other ways coaxing medicine 
in another, non-institutional direction. My results allow me to make an impact 
statement about the use of hookworm in medical practice.  
I used a mixed-methods approach to triangulate answers to these questions. 
First, a descriptive narrative drawn from literature on hookworms, helminthic 
therapy, and biome depletion provides context for my questions. Second, audio-
recorded, semi-structured interviews with Crohn’s disease patients, doctors, 
helminth providers, journalists, and other medical personnel conducted 
primarily in New York City and the San Francisco Bay area gave me access to 
both emotive accounts and insider information on the topic. Finally, online 
ethnographies of hookworm users and message board analysis allowed me 
access to a large amount of primary written information on hookworm therapy 
and its culture. Baxter and Eyels (1996) write about what makes research 
credible, dependable, confirmable, and transferable. In order to yield the most 
useful and trustworthy thesis research, I followed their guidelines in selecting 
research subjects and collecting and analyzing data. 
This project is anchored in two geographic subdisciplines, political ecology 
and science and technology studies. It engages theoretical concerns from these 
areas to articulate an opinion about the place of helminthic therapies in medicine, 
shed some light on complex political entanglements in medical treatment, and 
explore the experience of do-it-yourself medicine. It also creates a picture of the 
assemblage of humans and nonhumans involved in the issue of autoimmune 
disease. Because the role of the parasite itself is potentially unstable, this research 
brings up questions about uneven access in the field of health. Finally, this thesis 
will further our understanding of human–animal interactions and the 
commodification of nature through interrogation of some of the perceived 
fundamentals of biological and social scientific ontologies.  
 4 
CHAPTER TWO: BACKGROUND 
 
Autoimmune disorders on the rise. About 3 percent of the world population 
has at least one autoimmune disorder (Youinou et al. 2010). According to the 
National Institutes of Health (2012), up to 23.5 million people in the US—one in 
13—are suffering from autoimmune disorders today, including Crohn’s disease, 
ulcerative colitis, Hashimoto’s disease, Sjogren’s syndrome, and multiple 
sclerosis. The American Autoimmune Related Diseases Association (AARDA) 
(n.d.) estimates the numbers at more than double that. Millions more are dealing 
with asthma and allergies (Goldmutz and Penn 2010). Historical and spatial 
variances in reporting procedures notwithstanding (Bach 2002), the numbers of 
immune disorder cases is rising, according to studies in geoepidemiology (Logan 
and Bowlus 2010; Youinou et al. 2010; see also Strachan 1989; Beggs 2004; Hadley 
2006; Parker et al. 2012). In other words, the problem is not with under-reporting. 
Additionally, some disorders previously considered unrelated to the immune 
system, such as autism and depression, are now being explored as such 
(Velasquez-Manoff 2012; Thompson 2013). Despite this growing urgency, 
progress in clinical immunology has been slow (Parker et al. 2012). The 
traditional method of research in immunology has been molecular analysis of 
how the immune system works. The corresponding therapy is prescription drugs 
that suppress the immune system. These drugs constitute a multi-billion-dollar 
market (Mozeson and Shakhnovich 2013).  
Evolutionary medicine. It is difficult to pin down underlying causes for the 
rise in immune system disorders because epidemiology is largely inductive 
rather than deductive. There are various proposals: Hadley (2006) points to 
changes in food manufacturing and consumption practices in a study on food 
allergens. Beggs (2004) explores the possibility that global climate change is 
affecting ragweed and mold allergies. But many researchers are focused on 
another correlation, the link found between immune system disorders and 
industrialized, modernized regions with better sanitation, stricter hygiene, and 
more processed amenities for consumption (Logan and Bowlus 2010; Youinou et 
al. 2010; Parker et al. 2012; Koloski et al. 2008). 
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The biome depletion theory, also known as the hygiene hypothesis and the 
“old friends” theory, may provide answers (Parker et al. 2012; Hadley 2004; 
Strachan 1989). If true, these theories imply that it’s our very hygiene—our lack 
of microbes and parasites—that is causing this rise in the prevalence of immune 
system disorders. If true, researchers, clinicians, and patients may wish to turn to 
a corresponding treatment: biome restoration, which may prove safer and more 
effective than conventional immunosuppressants (Parker et al. 2012; Pollan 2013; 
Bilbo et al. 2011).  
Broadly, if biome depletion means that we are missing old microbes and 
macrobes from our environment (and thus, inevitably, from all parts of our 
bodies, mouth to gut to spinal cord), biome restoration is the equivalent of 
“rewilding” these places and reintroducing microbes and macrobes. L. bacillus is 
one that we’ve all heard of from yogurt, but some speculation asks about 
restoring H. pylori (which causes ulcers) and even the herpes simplex virus 
(Velasquez-Manoff 2012). However, much of the media fanfare about biome 
restoration is focused on the location of the gut (see figure 1). 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1. Some of the many news headlines about biome restoration with parasites. 
 
According to biome restoration, if we can restore the microbial ecosystem of 
the human digestive tract to be closer to way it was throughout the last two 
million years of human evolution, we might treat or even prevent these immune 
The New York Times: “Can hookworms protect against allergies?” 
(Svoboda 2008) 
 
Daily Mail: “Parasitic worms offer hope of cure for 
multiple sclerosis” (Whitelocks 2012) 
 
The Scientist: “Can Worms Alleviate Autism?” (Richards 2012) 
 
Wired: “Parasites, Modern Life and Immune Systems 
Gone Haywire” (Keim 2012) 
 
The Guardian: “Gut instinct: the Miracle of the Parasitic 
Hookworm” (Adams 2010) 
 
NPR: “Eat Your Worms: The Upside of Parasites” 
(Hamilton 2010) 
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disorders. Bacteria (McFall-Ngai et al. 2013; Pennisi 2013; Pollan 2013), helminths 
(Parker et. al 2012; Bilbo et al. 2011; Walk et al. 2010; Broadhurst et al. 2012), and 
even viruses (Pennisi 2010; Barton et al. 2007) may all beneficially shape the 
human immune system. The exact methods by which helminths and other 
internal organisms treat and prevent immune disorders (and possibly other 
chronic diseases) is still uncertain, but generally it works like this: Humans hand 
these organisms the job of immunomodulation (regulating the strength of human 
immune system reactions). This is an energy-saving measure that ensures them a 
hospitable and yet secure and well-functioning home: a balance between a robust 
human immune response and one that doesn’t accidentally damage our own 
tissues or the parasites within us. The approach point to a growing emphasis on 
evolutionary biology in medicine (Gorelick 2004; Thomas, Daoust, and Raymond 
2012; Nesse et al. 2009). Our health must be viewed in the context of evolved 
ecologies. 
Parker et al. (2012) point to four pieces of evidence for the connection 
between biome depletion (helminth loss in particular) and autoimmune disease. 
First, helminths produce molecules that calm immune response and stimulate 
our own immune regulator cells. Parasites as diverse as worms and the human 
immunodeficiency virus have been found to downregulate our T-cell (immune 
cell) responses (Sher et al. 1992), and further research has uncovered some of the 
specific chemicals that are responsible for this in helminth infections (Hewitson 
et al. 2009; see figure 2). 
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Figure 2. A sampling of the known immunomodulatory effects of helminths. From 
Hewitson et al. (2009). 
 
Second, according to Parker et al., humans rely on helminths for 
immunomodulatory function almost as much as helminths rely on humans for 
habitat. Humans have lived with helminths since before Homo sapiens were a 
distinct species. At the time, we lived in small, scattered groups that could not 
sustain a large population loss, so it was in the helminths’ evolutionary interest 
to remain relatively benign. The result was a compromise: helminths would take 
on the task of keeping our immune system from over- or under-reacting to 
stimuli—including helminth infections. According to Velasquez-Manoff, human-
dwelling parasites  
 
altered our immune function the way that atmospheric oxygen modified our 
lungs or dry land our limbs. This is to say, much of our immune system 
evolved precisely to manage the problem of parasites. They constituted a 
dominant feature of the landscape in which we evolved (2012, 23). 
 
Bilbo et al. write, 
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The evolutionary origin of jawed fishes more than 400 million years ago 
marked not only the appearance of immune systems containing all of the 
major components found in humans, but also presumably provided suitable 
vertebrate hosts for flatworm parasites. Although it remains unknown when 
in evolutionary history helminths took up residence in the vertebrate gut, 
several lines of evidence point toward helminths residing in the guts of 
vertebrates more than 100 million years ago (2011, 495). 
 
Today’s wild primates are teeming with parasites. We may have picked up 
worms from our time on the savanna—human tapeworms diverged from felid, 
canid, and hyena tapeworms, not domesticated animals’ tapeworms. That 
divergence happened 1 million to 2.5 million years ago, just as the genus Homo 
began to emerge, and long before the practice of animal domestication—in short, 
we may have given tapeworms to pigs, and not the other way around 
(Velasquez-Manoff 2012). The biome depletion theory points to our rapid shift 
away from this long-evolved state of cohabitation as a main factor in the rise of 
non-infectious immune-related problems. Whether through sterilized water 
sources, antibiotics, modern plumbing, refrigeration, anti-parasite education, or 
helminth treatment campaigns, industrialization and the hygiene movement has 
greatly reduced our microbial and macrobial internal biodiversity. 
Third, immigrants moving from pre- to post-industrial societies have higher 
rates of autoimmune disease and allergies. This has been noted in studies from 
Hawaii, New Zealand, and Israel (Trowell and Burkitt 1981), though this could 
be due to any number of factors, such as changes in diet or fetal developmental 
conditions, as well as microbiome diversity (Bickler and DeMaio 2008). 
Fourth, the geographic prevalence of helminth infection has an inverse 
relationship with the prevalence of immune system disorders (see figures 3 and 
4). The geographies of helminth infection versus immune disorders is closely 
correlated with industrialization and hygiene factors, with more industrialized 
and urban areas featuring both fewer helminth infections and greater immune 
disorders (Bach 2002; Bilbo et al. 2011; Kondrashova et al. 2013).  
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Figure 3. An inverse relationship exists for regions of the world experiencing high  
rates of autoimmune disorder and those with higher incidences of helminth infestation.  
From the web page of Coronado Bioscience (n.d.). 
 
 
 
Figure 4. A similar inverse relationship between the incidence of prototypical infectious 
diseases (panel A) and the incidence of immune disorders (panel B). From Bach (2002). 
 
 
However, for Parker et al. (2012), as for Okada et al. (2010), the proof of 
principle is in biome restoration experimentation, where helminthic therapy, 
fecal matter transplants (transfer of microbe-rich feces from one human to 
another) and other human biome treatments such as leeches, are tried on animals 
and humans with a significant (but inconclusive) degree of success. Examples 
include a study on human multiple sclerosis (Correale and Farez 2007), human 
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skin exacerbation (Flohr et al. 2006), human Crohn’s disease (Summers et al. 
2005; Croese et al. 2006), and rat diabetes (Like, Guberski, and Butler 1991). 
Experiments are ongoing, and will be explored below. 
The coevolution of humans and their microbial and parasitic landscapes has 
come to light in geographic thought already. Scott, Robbins, and Comrie (2012) 
believe this topic calls for an interdisciplinary alliance between physical, medical, 
environmental, social and political geographies. In order to better understand 
how diseases work, they think that we need to begin to look deeply at the co-
evolutionary relationships between species and the effects of institutional 
interventions, as well as the usual elements of habitat, exposure, and risk. We can 
view this not just on the macro scale, with world maps and geoempidemiology, 
but also on a micro scale, where some researchers are trying to understand the 
actual differences between animals with and without a helminth infection 
(Okada et al. 2010). 
My assemblage-style intervention especially emphasizes the importance of 
looking into human–pathogen relationships and the differences they produce. 
My work will add a specific case study to this literature in order to demonstrate 
the mechanisms by which the results of this microbial and parasitic coevolution 
with humans play out in the highly politicized field of modern medicine. 
Helminthic therapy. The hygiene infrastructure and practices that follow 
industrialization haven’t depleted internal biodiversity around the world. Two 
billion people still carry at least one of three major helminthic parasites: 
hookworm, whipworm, and giant roundworm (Despommier 2013). These 
worms are regularly battled by development and humanitarian organizations 
with an arsenal of awareness campaigns, shoe provisions, latrine building, and 
pharmaceutical anthelminthic drugs (USAID 2012a). Currently, 500 million 
people are treated each year with preventative anthelminthic drugs alone (World 
Health Organization 2010).  
However, helminths are now being seen as palliative as well as pathogen, as 
helminthic therapy stands to become an effective form of biome restoration. It is 
where helminthic parasites are no longer a major public health concern that they 
are used for treatment of immune disease. Treatment involves inoculating a 
patient with a specific number of helminthic worms orally or topically 
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(depending on the organism). They eventually land in the small or large 
intestine, where they interact on a molecular level with the human body (Loukas 
and Prociv 2001; Hewitson, Grainger, and Maizels 2009), negotiating a habitat 
tolerable to the worms as well as the human. Currently, live helminths are being 
tested in clinical trials by a limited number of pharmaceutical companies 
interested in their effectiveness and marketability1 (Summers et al. 2005; 
Pritchard 2009; Emara 2013; Richards 2012). Some believe that the beneficial 
molecules produced by parasites would be better extracted and put into a 
standardized pill-type form (Okada et al. 2010; Ruyssers et al. 2008). Researches 
are making advances in this extraction (Hewitson, Grainger, and Maizels 2009), 
but the individual animals’ variability may make both lab experiments and a 
viable, standardized, biologically derived drug difficult to reproduce (Tilp et al. 
2013).  
Helminths are regulated by the FDA, and currently illegal to manufacture, 
distribute, or import in the US. According to a 27 March 2014 personal email 
from Hope Anderson, Consumer Safety Officer of the Center for Biologics 
Evaluation and Research, a division of the FDA, if a helminth “is used to prevent, 
treat or cure a human disease or condition, it would be regulated as a drug 
and/or biological product” (Anderson 2014). However, the rates of success 
reported in studies and anecdotally (Croese et al. 2006; Summers et al. 2005), as 
well as the less-than-stellar performance of immunosuppressants (Lichtenstein et 
al. 2006; D’Haens 2007), are leading many people in the US to bypass the FDA’s 
years-long safety- and efficacy-testing process. They turn to informal sources 
instead. A new underground economy has started, alongside a do-it-yourself 
helminth culture.  
Crohn’s disease and hookworms. In this project, I focused in particular on 
the use of hookworms for helminthic therapy, and in particular on Crohn’s 
disease. Hookworms are one of three popular choices for helminthic therapy, 
along with pig whipworms and human whipworms. They yield minimal side 
effects when administered in low numbers, and when its human host is receiving 
a nutritious diet (Bilbo et al. 2011). However, hookworms caused real harm to the 
                                                
1 Trials in the US are searchable on http://www.clinicaltrials.gov. 
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health of rural Southerners in the US in the nineteenth century (Brown 1976). In 
some places in Africa and Asia, severe hookworm infections still couple with 
malnourishment to cause serious physical, mental, and, according to aid 
institutions, economic problems (Hotez et al. 2006; USAID 2012b). The 
contradictions between hookworm as disease and hookworm as medicine 
illustrate how the contingencies of place and materiality interact to shape the 
medical and political meaning of the hookworm. In the US, a country that had an 
endemic hookworm population 100 years ago, autoimmune patients are 
forbidden from selling and importing (or, effectively, from obtaining) helminths 
as medicine, and must either fly abroad to get them, receive them from a fellow 
patient, or purposely cultivate them at home (“FDA Import Alert” 57-21 2011). 
They are not recommended by doctors or television advertisements. 
The presence of the hookworms in a Crohn’s patient often, to some degree, 
calms the amount of inflammation experienced, though the exact mechanisms of 
immunomodulation in the disease are not yet understood (Okada et al. 2010; 
Maizels and Nussey 2013; Despommier 2013). Crohn’s is an autoimmune disease 
of the digestive tract. It is a disease that affects young, health individuals, with it 
most commonly beginning in individuals between the ages of 15 and 30. It is part 
of the family of inflammatory bowel diseases, which affects 1.4 million people in 
the United States alone (Loftus 2004). According to the Centers for Disease 
Control and Prevention (CDC) (2011), Crohn’s causes ulcers to erupt along the 
intestinal wall, and can result in severe pain, dysentery, malnutrition, anemia, 
and intestinal obstruction. Crohn’s may be treated with careful dietary 
restrictions, non-steroidal anti-inflammatory drugs, steroids, 
immunosuppressants, or iron infusions. Each treatment has varying success 
rates. The CDC (2011) further states that two-thirds of patients will eventually 
need some kind of surgery, since the drugs often eventually stop working. This 
may mean either getting sections of the intestine removed or colostomy. Each 
treatment, save dietary changes, yields a full spectrum of mild to severe side 
effects. For some people, the side effects become barely tolerable, and there is a 
relatively common fear of rare cancers and infections resulting from the stronger 
treatments. Sites like the CDC’s never list mortality as a prognosis, but some 
people with Crohn’s disease certainly do blame Crohn’s, its medications, and the 
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associated weakened immune systems, when friends die young because of 
diseases like pneumonia. 
Parasite pirates. Once patients and entrepreneurs recognized helminths as a 
viable treatment, they became a commodity for sale, and once they became a 
commodity, the FDA stepped in. In 2009, helminths were ruled by the FDA to be 
a biological pharmaceutical drug. At the time that this distinction was made, the 
US was hosting ongoing clinical trials of pig whipworm and at least one 
unregulated company selling whipworm and hookworm. The unregulated 
company, now called Autoimmune Therapies, was run by Jasper Lawrence. The 
FDA promptly raided his house after the ruling. He now sells helminthic therapy 
from the United Kingdom.  
Lawrence is often touted as the first do-it-yourselfer in helminthic therapy. 
He is not trained as a doctor; rather, he sought out hookworms after hearing 
about the therapy from his aunt. After a bit of research, he landed on the hygiene 
hypothesis. He decided to acquire hookworms the old-fashioned way—by 
mucking around in human feces near a designated bathroom area (in his case, in 
Cameroon). Lawrence’s debilitating allergies and asthma were suddenly better, 
and he was able to completely stop his prednisone steroid treatments. Further, 
the side-effects of hookworm treatment were minimal. He began selling his own, 
self-produced stock of hookworms out of his home by 2006, and continued 
distribution for three years before the FDA raid (Adams 2010). After the raid, his 
choices were to shut down the distribution or leave the country, so he left. 
Patients like Lawrence’s must now smuggle hookworms into the United States 
from Autoimmune Therapies or other providers abroad. This is not illegal, since 
the hookworms are within the patients’ bodies during travel back to the US, and 
the FDA doesn’t regulate individuals (unless they are manufacturers, 
distributors, and importers). Still, it does confront both social taboos about 
parasites and FDA governance, as well as raising questions about the ways in 
which parasites stand to be commodified. 
Travel overseas isn’t the only way to become a “parasite pirate.” Providers 
can cost from $2,000 to $4,000 out of pocket for three years guaranteed 
infection—plus an international plane ticket. Some users set up home cultivation 
labs so they don’t have to rely on this path. Once infected, these parasite users 
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are a powerhouse of hookworm egg production—each female hookworm can lay 
up to 30,000 eggs per day. Public and private social media websites allows home 
cultivators to chat about hookworm reproduction and cultivation. Though rarer 
in the US than in Europe because of legal issues, some individuals even become 
hookworm egg donors, sharing their hookworms’ offspring with others in need 
who can’t afford a multi-thousand-dollar price tag. 
Because of the complex relationships within this situation, it lends itself to 
exploration as an assemblage. Hookworms and other parasitic helminths, the 
intestinal biome, patients, medical practitioners, governmental agencies, and the 
environment all play a role in the drama of Crohn’s disease and treatment. A 
geographic exploration of this assemblage has the potential to clarify how people 
engage with this lively helminthic therapy and what this engagement means for 
the way helminthic therapy facilitates or resists the status quo of institutional 
medicine in the US.  
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CHAPTER THREE: THEORY AND METHODS 
 
Social scientists could analyze the contradictions related to helminthic 
therapy using a range of theoretical frameworks. An uneven development angle 
(Hayden 2003, Guthman 2011) would portray how parasites are promoted as a 
palliative in the US and Europe even while the Gates Foundation and countless 
NGOs dedicate millions of dollars and much labor toward their eradication 
(Brown 1967; World Health Organization 2013). Social constructivism (Metzl and 
Kirkland 2010) would document how ideas about parasites depend upon context 
(Naslund 2012), using the good-animal-versus-bad-animal motif common in 
animal geography (Wolch and Emel 1998; Buller 2013). A biopolitical approach 
could excavate the history of clinical and scientific medicine and the creation of 
self-governing, healthy biocitizens (Foucault 1973; Foucault 2009; Metzl and 
Kirkland 2010, Mansfield 2012, Rutherford and Rutherford 2013) or expand it 
into a study of biosecurity (Braun 2007). Rejecting any of these theories would 
limit a holistic, nuanced perspective of the human–helminth relationship. 
Though not the explicit goal of my research, an assemblage-based, affective, 
material account will set up a narrative through which many pieces of the 
puzzle, including the above economic, constructivist, and biopolitical theories, 
can be linked together.  
Assemblage. Assemblage is an interconnected field of elements in which the 
relationships between the elements are more important than the elements 
themselves. Robbins and Marks (2010) explore assemblage as a way to tell a 
complex story and better understand how relationships between humans and 
nonhumans unfold. Based on Deleuze and Guattari’s (1987) writings, an 
assemblage is a network of connections in which the constituent parts—human 
or nonhuman—are only important in as far as they are relating to one another. 2 
Deleuze and Guattari  (1987, 17-21) sum this up with the equation of assemblages 
= n - 1, where “n” is always minus 1. “n” is the number of elements in an 
assemblage, and “-1” means that you must always discount the subject of any 
assemblage. We can see that the assemblage itself exists only as the relationships 
                                                
2 See also Bennett (2010, 23-24) for a useful discussion of “non-totalizable” assemblage. 
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between this would-be subject and many other elements, not as the causation 
triggered by that subject itself. It is from this type assemblage based not upon 
human subjectivity or, indeed, any subjectivity, that I draw the notion of 
posthumanism into my thesis—or, perhaps better put, the postsubjective. 
Everything in the world is ultimately linked; however, it is possible to delineate 
parameters of a particular, smaller assemblage for the purposes of study. One 
effect of the assemblage view is its undermining an anthropocentric conception 
of agency and intentionality, as all parts of an assemblage contribute to any given 
phenomenon. 
Affect. The second concept is affect, or the way in which the relationship 
between two bodies makes a difference to those bodies. Affects, according to H. 
Lorimer, are “properties, competencies, modalities, energies, attunements, 
arrangements and intensities of differing texture, temporality, velocity and 
spatiality, that act on bodies, are produced through bodies and transmitted by 
bodies. Our sensual worlds catalyze complexly and dissipate unexpectedly” 
(2008, 2). Affect is not a property of a given subject, but rather runs along the 
lines between elements that we have already established as the main content of 
an assemblage. Affect, therefore, is not a given attribute, but something that is 
always becoming, along with those lines of relation. We can’t look at a pre-
existing affect any more than we can look at a pre-existing subject. Affect, unlike 
language, may not possess immediately decodable meaning; rather, humans and 
nonhumans must “learn” to be affected. The notion of learning to be affected is 
derived from William James (1890) via Vinciane Despret (1994) and Bruno Latour 
(1994). From this lineage, I take “learning to be affected” to mean the process 
through which two elements come to be engaged in a relationship with one 
another—a relationship that is signified by its rendering the elements different 
from how they would have been otherwise (Whatmore and Hinchliffe 2010). 
Bingham refers to Latour in studying “the process of how our bodies are 
“‘effectuated’, moved, put into motion by other entities, human or nonhuman” 
(2006, 489), and Latimer (2013) argues that humans learn to be affected alongside 
nonhumans—the connection is situated in a context, not inherent in a 
relationship. 
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Affect is a response, event, or action that is stripped of its representational 
qualities. Affect can be a combination of physical and mental-emotional 
pressures, and usually makes more of a difference when it is repeated over and 
over. When Whatmore and Hinchliffe (2010) write about people’s everyday 
relationships to urban green spaces, McCormack (2007) writes of psychotropic 
drugs and neuron firings, Bingham looks at how bees, butterflies, bacteria, and 
genetically modified crops interact, or J. Lorimer (2007) writes of nature 
conservation due to animal charisma, they are exploring affect. Others 
geographers specifically exploring affect include Hinchliffe et al. (2005), H. 
Lorimer (2006), Graham and Roelvink (2010), and Anderson (2009).  
The reason I use learning to be affected rather than just being affected is in 
order to imply that there is a temporal process, albeit an ongoing process, that 
must happen before species and individuals can be affected. However, the 
learning must always accompany affect because even before the affect of contact, 
there is an affect of separation.   
Materiality. The third concept is materiality. A material framework insists 
that social constructivism has limits, and instead takes affect into account. Social 
constructivism remains a preeminent analytical tool for many geographers, but it 
omits the parts of human (and nonhuman) existence that don’t entirely rest on 
language, semiotics, symbols, and grammar. Constructions must still be based on 
some perceived difference (Saldanha 2010; Barad 2003), and affect, itself 
producing difference, provides that grounding. This difference is also a source of 
contingency: “Once the body that is learning to be affected becomes articulate 
in/with a new world of things then both can start to change” (Whatmore and 
Hinchliffe 2010). For Bennett, following Spinoza, “The process of modification 
[difference-making, mode-changing] is not under the control of any one mode –
no mode is an agent in the hierarchical sense. Neither is the process without 
tension, for each mode vies with and against the (changing) affections of (a 
changing set of) other modes, all the while being subject to the element of chance 
or contingency intrinsic to any encounter” (2010, 22). 
A material framework doesn’t write off discourse, but rather contextualizes it 
as discursive practice. Together, discursive practices and material phenomena—
both of which are performative, active, and ongoing—constitute our world. 
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Haraway (2007) points out that rather than humans being cut loose from the 
material world in a state of human otherness, we are becoming who we are 
alongside them, in the midst of our material and emotional interdependence. She 
points back to the affect of ordinary, everyday relationships, and asks us to 
image what other species might be thinking as they do their part to colonize us 
just as we are colonizing them. I do not take her up on this prompt in this thesis, 
but I do follow her notion of “becoming with” to the culture-saturated 
microbiology of helminthic therapy. Barad’s notion that “Relata do not preexist 
relations” (2003, 815) captures the element I am most trying to capture: 
relationships themselves are constitutive of any individual elements in that 
relationship. Barad takes this approach because representationalism inevitably 
becomes trapped by its own metaphysics—one in which language is all there is 
at base, and performance or relationships are simply effects of language. A 
material framework made up of performed and learned affective relationships, in 
contrast, points to a world that is ever becoming. It opens up “particular 
possibilities for acting at every moment, and these changing possibilities entail a 
responsibility to intervene in the world’s becoming, to contest and rework what 
matters and what is excluded from mattering” (Barad 2003, 827).  
Others have already used this relational approach to pathogens before. Scott, 
Robbins, and Comrie (2012) contend that in order to better understand how 
diseases work, we need to look deeply at the co-evolutionary relationships 
between species and the effects of institutional interventions as well as the usual 
elements of habitat, exposure, and risk. Their assemblage-style intervention 
emphasizes the importance of looking into human–pathogen relationships and 
the differences they produce with illustrative case studies in bacterial and 
helminth infections, West Nile virus, and the fungal infection known as Valley 
Fever. Greenhough (2012) uses the idea of affective encounters to approach her 
study of the common cold virus. She writes about how humans and viruses learn 
to be affected by one another through embodied communication, and how this 
affect interacts with epidemiological research institutions and notions of the 
dangerous epidemic versus the endemic, everyday disease. 
Many concurrent, affective processes are associated with helminthic therapy. 
Some of these processes include: the altered microbial ecologies of the human gut 
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in developed countries; the transportation of hookworms from one country to 
another with contested degrees of legality; the disturbance of social taboos 
against parasites; chemical interactions between host and parasite bodies; the 
emergence of a symbiotic relationship between human and hookworm; the 
emergence of new sources of medical information; and the commodification of 
an organism. The human–hookworm assemblage, embedded in its intestinal 
territory, exists amid this “turbulence of articulations” (Whatmore and Hinchliffe 
2010, 447). Instead of treating a hookworm-infected gut or ova-laced patch of soil 
like a passive backdrop, as is often the case in traditional cultural geography, or 
like a decisive factor, as in environmental determinism, an assemblage-based 
ontology will allow me to explore the multivalence of this human–hookworm 
relationship—how it comes together in different ways to create new and 
evolving meanings and material realities. 
These three principles politicize my project and provide ethical guidance. 
Assemblage and affect are ways of understanding the world that, in their stark 
notice of the many elements that exert force on our lives, give us the opportunity 
to break from our engrained performativity. For Woodward and Lea, “the 
perspective of affects rails against such tautological and exculpatory givenness” 
(2010, 159), it rails against this hard-to-change performativity. They differentiate 
between “the capacity to negatively affect,” which can “pre-empt and delimit 
that group’s ability to affect the world” (159), and positive affects that can take 
place in “sites” such as, in this case, the helminth-infected gut. Following 
Woodward et al., the helminth-infected gut might be “where the unpredictable 
eruption of minoritarian events and spaces can produce specific and potentially 
transformative theoretical and political solutions that are anti-racist or anti-
capitalist or pro-autonomy and pro-questioning” (2010, 278).  
Note, however, that this radical openness is not inherently progressive. The 
contingency wrought by affect only undermines the notion teleological, 
predetermined futures. It still relies on human and more-than-human decision-
making in response to a given affective site, and could as easily lead to a cruel 
decision as a mutualistic one. Rather, it is the understanding or perception of 
affect that grants a progressive slant to this site-based affect. It is not knowledge 
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that there are things to change in the world that needs to be imparted; rather, it is 
the knowledge that we could make those changes that is missing. 
The same is true in the context of Bennett’s political approach (2005; 2010). 
For her, we have more possibility of impacting the world once we take a realistic 
view of the forces we face, rather than by pointing a finger at one guilty agent 
whom we naïvely presume to be functioning independently (Bennett 2005). 
Bennett gestures to this by rolling historical-materialism into her approach as 
opposed to liberalism or humanism. However, she wishes to go a step further 
than Marx by invoking more meaning and agency in objects and nonhumans 
than the concept of reification is able to provide—she calls for a “dogged 
resistance to anthropocentrism” (2010, xvi).3 
Robbins and Marks (2010) also use assemblage to political ends. For them, 
assemblage genealogies are not just for use in social movements, but can also 
have a profound impact on policy decisions, as faulty assumptions based on an 
ontology of human-only agency are toppled and more detailed descriptions 
drawn up. 
In the human–hookworm assemblage, affect is the corporeal communication 
that prompts new meanings and material differences to emerge. This emergence, 
in turn, indicates just how contingent our futures are. It has implications not only 
for how we view parasites and our bodies, but also for the politics of medicine. 
All relations are historical without being predetermined, so helminthic therapy 
can challenge how medicine has functioned in the past and how it might change 
in the future. 
Research questions. The above directly informs my two research questions, 
as I seek to understand the practical and political implications of the affective 
lines running between a parasite and a host. Parasitism is a ubiquitous but oft-
disregarded form of interspecies interaction (Combes 2001). My first research 
question asks how people learn to be affected by hookworm. The process begins 
                                                
3 This critique of Marx may be contested, however. Marx himself was cognizant of the way that 
nature and humans were split, and we find in Pre-Capitalist Economic Formations (Marx and 
Hobsbawm 1965) that his division between humans and nature (and, perhaps, all nonhuman 
objects) is less essentialist than people commonly think. He places humans and nature so close 
together that they may be seen as two sides of the same coin rather than a dialectically-related 
dualism. 
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when political economy, human illness, helminth reproduction, and medicine 
come together in the material practice of applying hookworm eggs to skin, 
initiating a new parasitic relationship, and fills out as people, culture, and 
hookworms change together.  
My second question addresses the outcomes of this host-parasite affect. The 
human–hookworm assemblage and the difference it produces create and change 
medical knowledge and practice. Hookworms and their human hosts engage in 
chemical interactions that barely pause from one generation of hookworms to the 
next or from one human host to another (Despommier 2013). Informal cultures of 
knowledge about how to use hookworms and judge their efficacy emerge from 
this chemistry, and ultimately, it creates potential new niches for this animal in 
today’s medical complex.  
Question 1: How do humans learn to be affected by hookworms? Braun 
writes, “Too much research…sets out simply to demonstrate emergence…. Isn’t it 
equally important to attend to how organization occurs?” (2008, 675). I aim to 
show not just that affect (and thus emergence, contingency, instability, and 
uncertainty) exists, but also how various elements in the human–helminth 
assemblage learn to be affected. J. Lorimer (2007) lays out a version of these 
processes explicitly. For him, animal affect can move into three types of 
charisma: ecological, aesthetic, and corporeal. Hookworms can potentially also fit 
into these categories. Ecological charisma has to do with the ways in which an 
animal evolved in relation to humans. Hookworms’ position literally embedded 
in humans in a physical manner throughout time played a huge role in their 
detestability 100 years ago and plays one in their desirability today. Aesthetic 
charisma (see figure 5) plays a role as well. Hookworms’ electron micrographs 
lend them to monsterization, often resulting in a strong “yuck” response, as well 
as anthropomorphization and an accompanying companion-animal status. The 
heads of tapeworm, whipworm, and roundworm simply do not evoke the same 
responses. Finally, corporeal charisma, or the impact of hookworms on the 
human body during direct contact, plays out two-fold. First, it may be related to 
initial contact between human and organism, as during an initial infection with 
hookworms, which is said to produce a “high” feeling. Second, it may be related 
to getting to know the animal over continued, everyday contact, as people with 
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hookworms come to speak of them affectionately over time. Far from pointing to 
environmental determinism, each of these affective performances could go in 
very different directions—for example, consider how the hookworm may be 
painted as monster or pet, or may produce sickness or health. The material 
hookworm has something to do with these responses, and yet the multifarious 
directions we, the affected, make of these responses allows for myriad possible 
futures. 
        
Figure 5. The aesthetic charisma of hookworm. The left depicts a scary hookworm electron 
micrograph (Bourbontrails 2009); the right depicts a cute hookworm out of felt (Chalmers 
2012). 
 
The act of learning to be affected positions discourse and social construction as 
outcomes rather than causes of material performances. The fact that we must 
always learn to be affected points to flexibility and changeability within a 
system, while socially determined construction remains static. If we let go of an 
ontology of mind-oriented representation, we will be freed to look instead at 
how interactions and perceptions themselves influence affect and, thus, bodies 
(Braun 2008). Braun, in reflecting upon Hinchliffe et al. (2005), notes that to be 
effective, a conservationist must “first learn to be open to different ways of 
knowing and registering the presence of different animals” (Braun 2008, 672). 
Similarly, to be effective in producing new medical knowledge, the Crohn’s 
patient must first learn to be open to different ways of knowing and registering 
the presence of hookworm.  
Learning doesn’t require either the cognitive registration of a practice or a 
humanized will to perform. Theories of non-representation do not wish to 
continue to define agency with an anthropocentric circumscription of will, 
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intentionality, and subjectivity. Braun, referencing ideas of Deleuze and Guattari, 
speaks of  
 
the idea of a “layout” or a “coming together” of disparate elements, and the 
idea of “agency” or the capacity to produce an effect. The advantage of actant 
(and agencement [assemblage] even more so) is that it rejects notions of agency 
inherited from liberal humanism, regardless of whether one is speaking of 
nonhumans or humans (2008, 167). 
 
Alongside the notion of n - 1 introduced earlier, assemblages and their human 
and nonhuman actants (not agents) see practice, rather than language and 
cognition, as constitutive of sites of learning and knowledge (Braun 2008). A 
wider definition of agency in the context of performativity includes ethology 
(Hinchliffe 2008; Stallins and Kelley 2012), emotions and feelings (Pile 2010; 
McCormack 2005), entangled identities (Davies 2012), vernacular ecologies 
(Whatmore and Hinchliffe 2010), and the aforementioned charisma (Lorimer 
2007). Again, performativity as a means of knowledge- and world-making isn’t 
inherently progressive (Butler 2010), but understanding performativity, and 
perhaps more importantly for this case, the permeability of the body, indicates a 
possible point of reterritorialization. 
Learning to be affected is the performativity of the creation of difference. For 
Whatmore and Hinchliffe, “The more you learn to be affected, the more 
differences there exist” (2010, 446). Some of the differences created in this case 
include how two hookworms will act differently within the same human body, 
or how two humans would react differently to the same hookworm chemicals or 
hookworm advertisement. In this way, two very different, contradictory, aspects 
of the helminth infection, first as illness and then as cure, begin to emerge. Affect 
and the creation of difference don’t end on the individual scale, however. They 
also reach into the social level, where multiple political and medical futures are 
waitng to emerge. This brings me to Question 2. 
Question 2: Which aspects of hookworm therapy aid incorporation into 
institutional medicine, and which hinder incorporation? Uneven medical, 
social, and economic practices emerge from the human–hookworm assemblage. 
Medically, tensions build between simple germ theory and the hygiene 
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hypothesis,4 and between anecdotal self-experimentation and clinical lab 
experimentation. Socially, some people are validated by hookworm infection, 
while others remain alienated. Economically, hookworms become valued 
differently depending on the laws surrounding them. These contradictions 
invoke what Bingham and Hinchliffe might call a multinaturalist take on the 
geography of medicine: “what we are seeking here more broadly is not a way of 
mediating different (cultural) takes on a single (natural) world, but in learning 
how we might better articulate (and articulate together) manifold modes of 
living” (2008, 84).  
I expect that affect’s creation of difference both aids and hinders the 
incorporation of hookworm knowledge into formal medical treatments. From 
that starting point, I seek to understand the incorporation of a living organism 
into medical treatment affects the potential of that treatment and how this 
treatment is being rejected, received and reconceived in established medicine. 
Hookworms can both borrow from and push back against the stringent 
ontologies of institutional medicine (Mol 2002). Animal charisma is useful for 
biochemists and hookworm bootleggers alike. Pharmacogenomics practices 
(Dove et al. 2012) may both steal from and provide for do-it-yourself helminthic 
therapy communities. 
Whereas classic production-of-nature theses (Castree 2000; Bird et al. 1996; 
Smith 2007, 2008) identify how organismal goods and services readily join 
circuits of capitalization (Cooper 2012; Hayden 2003; Bakker 2010), there are 
aspects of helminthic therapy that seem to work against a complete and final 
incorporation into the formal medical establishment. For example, while 
helminthic therapy has become a crowd-sourced citizen science (Dove et al. 2012; 
Cooper 2012), with large portions of information generated in online forums and 
groups, this citizen science both individualizes medicine in a neoliberal manner 
and communalizes experimentation by and for patients. This research question 
will inform us about the crisis in health care, the shifting role of social media, 
                                                
4 The germ theory of medicine states that germs, rather than bad air or divine agency, can cause 
disease. The hygiene hypothesis does not, of course, supplant germ theory, but it brings to light 
some of the false assumptions that arise out of it, like that all germs are bad and cause disease. 
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individual medical experimentation, and citizen science in the construction of 
health knowledge and practice.  
The power of helminthic therapy is built upon recognition of difference—in 
human bodies and in hookworm bodies. These differences—this individuation—
should not be used to reduce humans and hookworms simply to diverse subjects 
at the expense of social justice (Roberts 2010). Instead, these organisms form a 
multitude that, together, experimental science must contend with, and that, 
together, present the possibility of new affective relationships and new futures 
(Davies 2012; Saldanha 2006). Further, being able to show that helminths are 
affecting humans not just differently between humans, but differently depending 
on social setting, points to areas in which work must be done to rectify economic 
inequality. My questions tease apart these contradictions and differences in 
bodies and health in order to show contingency and hence engage socio-political 
possibility. 
Rather than attempting to formulate hypotheses from my research questions, 
the questions evoke stories, which in turn evoke theories. The process in which 
theory is formed from the data collected, rather than collected data proving or 
disproving hypotheses, is called grounded theory (Corbin and Strauss 2007). It is 
especially useful in cases such as this one, where the subject matter is complex, 
actions and relationships are at the heart of the study, and social constructions 
and material phenomena influence each other continually. Not posing a 
preconceived hypothesis avoids inadvertently skewing results with biases and 
misrepresenting the information I gather. Ultimately, neither of these questions 
will tell me if, indeed, helminthic therapy works, or what percentage of Crohn’s 
patients want to try it. However, they do provide a complex analysis of social, 
political, medical, and economic forces, and thus enable me to make certain 
recommendations regarding this new therapy and medical practice in general 
going forward.  
Epistemology. Assemblage geography focuses on a set of entangled 
relationships and the affect that flows along them. In framing what a researcher 
is studying, assemblage is also a method of study (Robbins and Marks 2010). 
Further, like in quantum physics’ double-slit experiment, as soon as you observe 
a given assemblage, you become a part of its affectivity (Barad 2003). Thus, my 
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method had lead me to carefully choose who I study, who I wish to write for, 
what I wish to affect, and how I go about intervening. While I tried to minimize 
my interference in any ways that would bias the answers I received from 
participants, I hope that my research practice, including announcements seeking 
volunteers, conversations with people I encountered at the research sites, and the 
interviews themselves, provoked thought on this topic (Woodward et al. 2010). 
Assemblage calls for a methodology that can account for its complexity and 
lack of final causative correlations. Deleuze and Guattari (1986) write that 
assemblages allow for their own reterritorialization—in other words, there may 
always be a piece of an assemblage that may escaping and then reworking the 
larger unit. As a method, acknowledging that I am writing an assemblage 
description allows my performance of critique to escape the confines of the 
system of which I am a part, and grow into something that can more deeply 
transform the field of critical health geography. 
Further, I use an assemblage method because it allows us to go beyond the 
subjective actant and cause-and-effect. Robbins and Marks (2010) note that 
assemblage perspectives make it difficult to determine cause and effect or 
explain definitive undebatable “whys.” By looking at human, hookworm, and 
associated elements as part of an assemblage, and constructing a complex 
narrative about them, we can come to see how each part touches others through 
affect, not human-like agency, leading to a deeper understanding of the oft-
neglected nonhuman side of the story, and of how these vernacular ecologies 
come to be formed.  
To gather information for this descriptive narrative, I engaged mixed 
qualitative methods: descriptive narrative, semi-structured interviews, online 
ethnography, and analysis of message boards. My target human subjects were 
patients with Crohn’s disease using hookworms, though I ended up 
incorporating some stories from subjects with other immune disorders or who 
are using pig or human whipworm rather than hookworm. Besides conducting 
semi-structured interviews with these subjects, I also spoke to two doctors, one 
helminth provider, one website entrepreneur, and two journalists. Most of my 
interviewees lived in New York City and the San Francisco Bay area, but two 
lived in New England, and three lived outside the US. Most of the interviews 
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were in person, but some were via email and telephone. The online ethnography 
and analysis of message boards took place on popular social media websites. 
Online ethnographies. It is on popular social media websites that, for years, 
patients have formed unofficial networks of knowledge with one another, 
lending information and advice that persuades or dissuades inquirers from 
trying hookworm. I follow various internet groups and message boards on 
supporting helminthic therapy users, discussing how to use and cultivate 
helminthes, biome reconstruction, and human bacteriology. Discussions and 
posts I follow range from simple inquiries about whether helminthic therapy will 
work for a specific ailment, to detailed stories of self-experimentation. I will not 
state the names of these groups or the websites that host them to prevent any 
possible repercussions on patients and providers. 
I took a minimal role in these groups, and gathered data mainly as an 
observer. Using methods from Robert Kozinets’s 2010 Netnography: Doing 
Ethnographic Research Online, I used these internet groups to observe how users 
interact, form connections, and exchange and shape knowledge. For Kozinet, we 
need to be extra careful not to violate online users’ privacy due to the uncertain 
public/private definition of online spaces. Using care, I found that online 
ethnography gave me a window into one of the main means of communication 
around helminthic therapy, and placed me in the same position as many of my 
subjects for whom internet observation is their main form of participation. 
Interviews with helminthic therapy patients. I conducted semi-structured 
interviews with Crohn’s disease and other immune system disorder patients (see 
figure 6). These disorders can affect all aspects of a person’s life, it’s important to 
maintain confidentiality for all patient-subjects. The patient may need access to a 
bathroom very frequently, may experience severe pain, may require heavy 
pharmaceutical drugs, and may even need to get sections of the digestive tract 
removed. Crohn’s patients usually experience flair-ups interspersed with periods 
closer to normal function, meaning that symptoms can range from mild to severe 
in a single case. Because of the tenuous legal nature of helminths therapy today, 
and because of the sensitive medical information being described and its 
possibility of social and professional stigma, I will protect the identity of my 
participants in all my published work by using pseudonyms.  
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 Pseudonym 
On 
helminthic 
therapy? Location 
Medical 
condition 
Interview 
method (semi-
structured and 
audio recorded 
unless email) 
Age / Gender / 
Occupation 
1 Ann Yes Northeastern US Crohn's disease in-person 20s, female, student 
2 David Yes Australia 
Crohn's disease 
and multiple 
other video chat 
20s, male, world 
traveler 
3 Dixie Yes Northeastern US Multiple other phone 
40s, female, 
medical worker 
4 Greg Yes SF Bay area 
Severe allergies 
/ asthma in-person 
40s, male, 
programmer 
5 Hugh Yes New York City Crohn's disease in-person 30s, male, finance 
6 Jill Yes United Kingdom Eczema email 20s/30s female 
7 Karl Yes New York City Crohn's disease in-person 30s, male 
8 Ken Yes New York City Allergies in-person 
20s, male, 
computer 
programmer 
9 Molly No New York City Crohn's disease in-person 
late teens, female, 
student 
10 Reina No New York City Crohn's disease in-person 
late teens, female, 
student 
11 Ronald No Southern US Crohn's disease email 
20s, male, 
computer engineer 
12 Shelly Yes SF Bay area Severe asthma in-person 
30s/40s, female, 
designer 
13 Sonia Yes SF Bay area Multiple other in-person 40s, female 
14 Tori Yes Canada Crohn's disease video chat 30s, white, female 
  
Yes = 11 
No = 3 
NY City = 5 
SF Bay area = 3 
Crohn’s = 8 
all other = 6 
in-person = 9 
all other = 5 
female = 8 
male = 6 
 
Figure 6. List of all patient interviewees (excludes professional interviewees, even those on 
helminthic therapy). 
 
Patients were given the opportunity to describe the process of learning to be 
affected, whether through acute pain that may have motivated starting 
helminthic therapy, the emotional responses and intimacy of living with the 
hookworm, or any of the everyday, “vernacular” practices that arise.5 Some of 
these patients were affiliated with helminthic therapy clinics. Others were 
patients who reproduce and reinfect with hookworm at home. These at-home 
practitioners provided valuable information about do-it-yourself processes, 
concepts of medical expertise, and legal concerns. The group is diverse in other 
ways, too. Their politics varies, as does their level of involvement with deciding 
about their medical treatments. What they do have in common is that they all 
have difficult, chronic diseases, and they are all seeking treatment for them. 
                                                
5 Please refer to Appendix for a list of interview questions. 
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By talking to Crohn’s and other patients who are on the hookworms, and 
asking them about the role these worms played in their personal stories, I gained 
assurance that that I obtained information from people who feel not just the 
discursive but also the direct material results of both illness and hosting. Crohn’s 
patients were be able to provide insight the way their bodies interact with the 
parasites, as well as the journey each side (human and hookworm) took to reach 
the other. Their answers are not likely to be replicated by another subject. Each 
person’s story is bound to be different. Thus, rather than attempting to draw out 
a statistical analysis of the resulting data, I use individual life stories as access 
points to case studies of particular human–hookworm assemblages. 
Interviews with both informal and institutional medical researchers, 
providers, and journalists. Following is a list of the public professionals I 
interviewed for this project. These professionals had sometimes conflicting 
viewpoints, but revealed some of the tension behind expert knowledge. They 
also gave some context to the socioeconomic processes behind hookworm 
therapy. See Appendix for an list of example questions. 
• Dr. Joel Weinstock, Tufts University, clinician and researcher in 
Crohn’s disease and whipworm, involved with tests on pig whipworm 
for Coronado Biosciences (interviewed in person) 
• Dr. P’ng Loke, New York University, parasitology lab researcher 
currently working with immunology and whipworm in lab mice 
(interviewed in person) 
• Jasper Lawrence, AutoimmuneTherapies.com, a helminthic therapy 
provider and commonly known as the first person to self-infect outside 
of a medical setting (interviewed on Skype) 
• Sean Ahrens, Crohnology.com, uses helminthic therapy for his own 
Crohn’s disease (interviewed by email) 
• Moises Velasquez-Manoff, journalist and author of An Epidemic of 
Absence (2013), self infected as part of his research (interviewed in 
person) 
• Sharon Shattuck, documentarian and ecologist, made the short film 
Parasites: A User’s Guide (2010) (interviewed in person) 
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The first two individuals above, Weinstock and Loke, are medical 
researchers. By studying not just the doctors’ words, but also their reactions to 
my questions, I can gain deeper insight into their affective involvement with the 
human–helminth assemblage. Their perspectives also informed me as to how 
helminthic therapies and the knowledge they produce inform institutional 
medicine. 
The third individual, Lawrence, is a private helminthic therapy provider. 
Clinicians, even those who focus on helminthic therapy, cannot recommend or 
prescribe the therapy to their patients until approved by the FDA. Although 
some researchers are using live helminths in clinical trials, helminthic therapy 
does not have FDA approval for non-trial distribution and sales. Thus, all 
companies producing and distributing helminthic therapy to the general public 
are located outside of the US. Thus, both clinicians and researchers in the US 
don’t come into contact with helminthic therapy users unless they are 
conducting a clinical trial or their patients decide on their own to seek out the 
worms. Thus, overseas providers are the only ones who come in contact with 
patients regularly. They possess a vernacular knowledge (Whatmore and 
Hinchliffe 2010) of the ecology and political economy of helminthic therapy. 
They are in touch with the same patients over long periods of time. Some 
patients require more worms every year. Other patients may need to send fecal 
samples to the provider for testing to make sure eggs—and therefore, the 
parasites themselves—haven’t been lost. Providers may therefore have more raw 
data than anyone else about helminth users as a group—indeed, what patients 
tell their online groups and what they tell their medical providers is likely to 
vary greatly. Lawrence heads helminth provider Autoimmune Therapies in the 
United Kingdom. Another helminth provider, Worm Therapy/Instituto De 
Terapias Alternativas Autoinmunes, is run by Dr. Jorge A. Llamas and 
Lawrence’s former business partner, Garin Aglietti in Tijuana, Mexico, and is 
frequented by US worm users. Ovamed, once affiliated with Weinstock’s 
whipworm trials, is located in Germany. I was able to gain an interview only 
with Lawrence. 
The fourth individual, Ahrens, started Crohnology.com, a website dedicated 
to building a community of Crohn’s patients and allowing researchers to gather 
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statistics on how well different treatments work. It falls somewhere between 
message board anecdotes and double-blind, placebo-based studies. It includes 
tabs for tracking mental and physical health, and treatments, as well as forums 
and ways to connect with other Crohn’s patients. Helminthic therapy is a 
recognized treatment on the site, and Ahrens, uses helminthic therapy for his 
own Crohn’s.  
Velasquez-Manoff and Shattuck provided me information about some of the 
struggles they came across while trying to formulate an unbiased report for the 
public on the subject of helminthic therapy. Both place an emphasis on scientific 
accuracy and unbiased research, so they provided me with a sense of balance 
and place a check on biases that may have crept into my research. 
Data collection and analysis. I used an audio recorder for all interviews 
when permitted, whether conducted live or over the phone or computer. Only 
one interviewee declined an audio recording. Having an audio recording 
prevented me from having to write notes the entire time of the interview for 
better interpersonal engagement. I also took notes of important points spoken by 
the respondents in a paper notebook. While handwriting is slower than I typing, 
I believe that a notebook will prove less distracting than taking notes on a 
computer, again allowing unfettered engagement with the respondents.  
Once all interviews were collected, I transcribed them. This functioned to 
immerse me in the information a second time, and to reminded me of pieces I 
may not have noticed at first. I did not formally code the interviews, but instead 
created a document with categorical headings and pulled excerpts from the 
transcripts into relevant categories. In the future, I believe a stricter coding 
procedure would be helpful. 
Rigor and reliability. Using Baxter and Eyels’ (1997) report on evaluating 
qualitative research, I attempted to sample interviewees and conduct interviews 
to best enhance credibility, dependability, and confirmability, and transferability.  
Attaining enough interviews so that a range of opinions emerged enhanced 
credibility. A semi-structured interview style and vigilance as to which prompts 
worked and which did not allowed me to pursue new questions as they came up. 
I used a combination of sampling styles. First, with targeted sampling I contacted 
key individuals outspoken on the Internet, producing respondents who were 
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well-versed in the issues and who were willing to “tell all.” Second, snowball 
sampling allowed me to speak with people I might not otherwise have 
encountered, or who are not part of online communities. Third, I reached out to 
individuals across the US and in other countries to ensure that I am got 
perspectives from people in both urban and rural social groups. One problem I 
faced is that internet users possibly skewed my sample toward particular social- 
and age-groups. On the other hand, information about helminthic therapy is 
largely available only online and not in doctor’s offices or on television, so it is 
likely that internet users are the primary population to hear about and use 
helminthic therapy. Gathering the responses of not just patients, but also a range 
of professionals, provided some balances. Also, the online ethnography 
component of the project also allowed me to double-check my findings.  
Dependability relies on my use of audio recordings, which I transcribed in 
order to draw out quotes and to compare between interviews. Conversations 
with my advisor, committee members, and peers about how my research went 
and my methods for analysis helped ensure that I don’t overlook any important 
pieces on information. My own field notes provided a level of confirmability, since 
I was be able to compare my emotional and intellectual responses from the time 
of the interview with my thoughts during the drawn-out process of analyzing 
and writing up my results. I am also in the process of running some of my results 
by at least one helminth user who I interviewed to ensure I maintained both 
confidentiality and accuracy. 
The fourth characteristic, transferability, presents a challenge to qualitative 
researchers, but an assemblage-based study is uniquely primed to cope with this 
challenge. One of the foundations of assemblage theory is that no two situations 
are alike—each is a singularity. But instead of taking this to mean that each study 
will be only of use in the particular case studied, assemblage, with its detailed 
descriptions of networks and interactions, can provide important information for 
other cases about human–animal interactions and its impact on medicine. 
Although my study does branch out from my original plan to study Crohn’s 
patients and hookworm only, I am careful to be specific in my descriptions so 
that receiving researchers will be able to clearly discern what will and won’t be 
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useful for them to take from this study. Specificity allows others to know what 
isn’t—and what is—transferable from my project. 
Representation can become a problem, especially in research on affect. 
Almost all research involves some form of linguistic representation, whether 
between subjects of study and researcher, or between researcher and readership. 
It is impossible to get an untarnished picture of the affective qualities of 
performative material subjects of study. Researchers studying representation and 
construction must be careful to critique their own constructions of the project. 
However, researchers taking a critical materialist perspective must be aware of 
the fact that representation, while not the sole object of study, still exists, and will 
impact the results of a project. Further, my representations of the project, my 
affective impacts on it, and the ways in which I learn to be affected by it will 
automatically reference my own position in the story. My tangential and direct 
relationships to autoimmune disease and the medical industry have 
undoubtedly impacted my thesis, so I have been careful to use dependability 
checks during data collection and analysis.
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CHAPTER FOUR: HOW HUMANS LEARN TO BE AFFECTED BY 
HOOKWORMS 
 
The physical and mental changes that humans experience when exposed to 
hookworms are not imaginary. These changes are part of how humans learn to 
be affected by hookworms. Descriptions have the power to elucidate this process. 
My descriptions below are based on interviews and online content about 
helminthic therapy. How humans learn to be affected by hookworms may be 
articulated as a number of steps. The steps I have defined as learning to be 
affected are (0) separation from hookworm, (1) turning toward the helminth, (2) 
overcoming the “yuck” factor, (3) acquiring hookworms, and (4) contact and the 
production of difference. These steps are the multiple lines of affect that tie 
together the various parts of the human–helminth assemblage. While these steps 
are often happening concurrently, they are also sometimes being skipped over, 
pieced together, and completely destroyed. These steps are, in reality, messy and 
overlapping, but I pull them apart below in order to make the process more 
intelligible. As Marks and Robbins (2010) mention, we are tied to language in 
order to render our understandings of assemblage. Do note that the words we do 
not use may have just as much to say as the ones we do use: any steps I leave out 
should also draw the reader’s attention. In the end, they must be seen in relation 
to one another, not as individual steps along a path toward effect.   
 
0. The phase between the hookworms: separation.  
The “phase between the hookworms,” implies a time period when humans 
were not infected with hookworms. This occurs when hookworms have been 
eradicated from a given human population, and have not yet been introduced as 
medicine. It is not pre-contact, but between contact. Although it is tempting to 
say that this is a stage during which we are not in relationship with hookworms, 
the absence of the hookworm only brings us closer to deconstructing our real 
relationship with them. Rather than explaining a pre-affective stage, I would like 
to present a stage in which our affective relationship to particular parasites—
namely, human hookworm and human whipworm—is that the two are not in 
physical contact with one another, and that the parasites are treated with 
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discursive disgust by humans. This “phase zero,” in which humans and 
helminths do not touch, is associated with various autoimmune diseases, 
allergies, asthma, and possibly a whole slew of other ailments, including 
depression. 
Humans have coexisted with hookworms and other parasites since before we 
could be considered human, and many of these parasitic species must live in 
humans exclusively. Humans have always been habitats and must remain so. 
Bacteria, for example, we already know to be essential to human digestion, and 
this is just the start for known commensal organisms. This kind of equilibrium is 
no utopia, and we can see this in the negative consequences of parasitic 
infections. However, it wasn’t until the last couple of hundred years that socio-
economic conditions, the culture of late capitalism, and medical technology came 
together to make eliminating parasites a desirable and realizable goal.  
Hookworm eradication started in the US South 100 years ago, where 
hookworm was endemic in many states until a public-private partnership, the 
Rockefeller Sanitary Commission for the Eradication of Hookworm Disease, was 
funded with a $1 million grant by John D. Rockefeller in 1909. The campaign, 
noted as the first modern public health effort, was sparked after an investigation 
pointed to hookworm as the cause for the supposed “laziness” of Southerners 
who hadn’t picked up factory work as quickly as hoped during the 
Reconstruction period (Ettling 1981; Brown 1979). The Commission on Country 
Life reported that “quite aside from the humanitarian point of view, the 
aggregate annual loss to the nation from insanitary conditions on the farms must, 
when expressed in money values, reach an enormous sum” (United States 
Country Life Commission and Bailey 1909, 46). Within a few years, the mission 
of hookworm eradication was spreading to Mexico, China, the Philippines, and 
elsewhere around the world (Birn and Solórzano 1999; Brown 1976).  
Today, a battle against many intestinal parasites (helminths) continues, fueled 
by a dual mandate of global health and economic success. In stating this second 
point, USAID’s website echoes the commission’s statement above:  
In children, chronic hookworm infection has been shown to impair 
physical and intellectual development, reduce school performance and 
attendance, and adversely affect future productivity and wage-earning potential 
(USAID 2012; italics added).  
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Further, anti-parasite (anthelmintic) drugs present a huge market opportunity 
for pharmaceutical companies. Although other methods, such as latrine-
building, exist, according to a study by the Disease Control Priorities Project,  
Until new technologies become available, anthelmintic chemotherapy for 
school-age children remains the most practical and substantive means to 
control STH [soil-transmitted helminths] and schistosome infections in the 
developing world (Hotez et al. 2006). 
 
Humans in the US and many other parts of the Global North are now rid of 
their intimate, but often pesky, companions. According to the biome depletion 
theory, however, this raises a new series of problems for human health. While 
epidemiology has for years considered human bodily equilibrium to be a human 
body without infections, this definition is changing. Sometimes infections may be 
necessary for equilibrium. Many interviewees had also reached this conclusion, 
and were adamant about the importance of balance and extra-human 
relationships. For example, Tori told me,  
We’ve evolved with helminths in our guts, and it’s become a symbiotic 
relationship, and if we don’t have them, to help train and modulate and 
moderate our immune system during your developmental years, which is 
the concept, then we throw the immune system off, so that it becomes this 
thing that does harm and attacks our body as opposed to help our body. 
 
Sonia, who found that parasites didn’t work for her disease, yet kept them 
anyway because 
our body expects to have some kind of parasites to be able to, for the 
immune system to be balanced, so I think they are a natural part of me, so 
that’s why I kept them. 
 
Likewise, filmmaker and ecologist Sharon Shattuck begins her film, Parasites: 
A User’s Guide (2013), with a quote from John Muir: “When we try to pick out 
anything by itself, we find it hitched to everything else in the universe.” The 
premise of her short film about helminthic therapy was this long evolved 
interconnection between humans and parasites, and the damage separation can 
do. 
One of the major helminth providers, AutoimmuneTherapies.com, writes 
about this stage of separation on the front page of their website: 
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Probiotic Immunotherapy safely and naturally restores nature’s balance to 
your immune system, quells inflammation, and stops tissue damage. 
Helminthic therapy, nature’s most powerful probiotic, harnesses nature to 
heal, restoring the helper organisms we co-evolved with and that our 
immune systems depend on to function correctly, and is based on 
sound science. 
 
Compare this to the official website for Janssen Biotech’s drug Remicade, which 
casts autoimmune as the defective presence of an immune system molecule 
rather than the absence of a relationship:  
People with certain diseases have too much TNF-alpha that can cause the 
immune system to attack normal healthy parts of the body. REMICADE 
can block the damage caused by too much TNF-alpha. 
 
For Moises Velasquez-Manoff, one of the major differences in this new 
perspective is the way that people are given a reason for their illness—this 
absence of helminthes—rather than having to blame their own faulty bodies for a 
presence: 
 
how alleviating to know that there’s a reason for your malady—that it’s 
not your fault, and that it’s not random. How terrific that the scientists 
exploring this treatment can explain these diseases in a way that the 
creators of immune suppressants and asthma inhalers can’t (2012, 276). 
 
In terms of evolutionary medicine, assuming a possible state of utopic 
equilibrium is impossible. Our health isn’t perfect whether or not we are infected 
with hookworm. Still, striving for balance tends to place hookworm in the realm 
of “good” instead of “bad,” which complicates a definition of health as 
infectionless. However, that is just where many people in the US are today: 
relatively infectionless. 
 
1. Turning toward the helminth 
People hear about helminths in all sorts of ways, but not through the 
mainstream medicine. Because the treatment is not FDA approved, a doctor 
could be sued for recommending it, even if they have read research about 
helminths and believe it could help their patient. Instead, patients often learn 
about helminths through home online research, the media, or even through jobs 
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in the medical field. Turning toward healing parasites is an active process, and 
one strong motivation is how they work in comparison to pharmaceuticals. 
Part of the reason autoimmune patients do extra research on alternatives is 
because often conventional drugs have serious or scary side effects and are only 
somewhat effective. People generally move up a chain of drugs as the effects of 
the previous drug wears off. These medications work better for some than others 
and tend to lose their effectiveness over time. Sometime, the drugs do not work 
well enough to prevent the need for surgical removal of sections of intestine, or 
colectomies. Biologic drugs are a final line of treatment for many patients. 
Biologics are highly complex, large-molecule drugs that are created with 
recombinant DNA technology and manufactured within living organisms or 
biological tissues. Throughout the course of this project, I heard two people talk 
about friends who got a rare soft-tissue cancer while on a biologic, at least one of 
them fatal. Others said that they, themselves, were on biologics, but felt it was 
risky. The websites for the biologics feature a prominent warning on their front 
page. Remicade’s reads:  
REMICADE® can lower your ability to fight infections. Serious and 
sometimes fatal events can occur. There have been reports of serious 
infections including tuberculosis (TB) and infections caused by bacteria, 
fungi, or viruses that have spread throughout the body. Lymphoma, 
including a fatal kind called hepatosplenic T-cell lymphoma, and other 
cancers have been reported in children and adults taking REMICADE®. 
Some people with heart failure should not take REMICADE®. Other 
serious side effects reported include skin cancer, hepatitis B, liver injury, 
blood problems, allergic reactions, nervous system problems, or lupus-like 
syndrome. 
 
One doctor I interviewed told me that these fears are exaggerated, because 
according to trial follow-ups, cancer rates were still negligible compared with 
how many people used the drug overall. Peer-reviewed medical journals 
reported ambivalent results (Lichtenstein et al. 2006; D’Haens 2007). Further, 
sometimes pharmaceutical companies start their own journals, complete with 
peer-reviewed articles, in order to propagate positive reviews of their drugs 
(Moffatt and Elliott 2007). The uncertainty of patients is, in part, what leads 
toward this turn. 
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Hookworms, however, are somewhat specialized (though increasingly 
indicated for more medical issues than before). They are not pre-assumed to be 
helpful, like diet restrictions or de-stressing, but rather must make themselves 
known. Something between shock value and charisma has allowed them into the 
popular media, and their relative effectiveness has helped them to spread by 
word of mouth and also in the medical community. Turning toward the 
helminth sometimes involved science media discourse. Dixie, who worked in a 
medical setting, told me: 
We heard a little about that as early as 1998 in the popular press. That’s 
when I got wind of all this, through the news feed for the hospital I 
worked for. 
 
Two interviewees weren’t getting better with pharmaceuticals and were 
facing more rounds of surgical removal of intestines. They both stumbled across 
Joel Weinstock’s research. Tori said: 
I was just literally looking at research, seeing what was coming out, and I 
ran into Dr. Weinstock and Summers’s article. They did a small study in 
Ohio, I think it was, and I just kept finding more material about helminth 
therapy to the point where it was just, I needed to try something else, I 
knew that my medication wasn’t working, I knew that they wanted to do 
more surgery, and I didn’t want to go that route. 
 
Hugh was pouring over research after yet another intestine-removal surgery: 
I read Joel Weinstock’s research. He was doing it before it had become 
popular in the media. He was doing it in the ’90s… 
A number of interviewees heard about helminthic therapy through WNYC’s 
public radio program Radiolab (Smullyan 2009). The show juxtaposed the 
harmful and helpful hookworm, and interviewed helminthic therapy pioneer 
Jasper Lawrence. Radiolab was also my own first introduction to the therapy. 
However, for Ann, listening to Radiolab with her boyfriend had to be followed 
up with extensive, self-motivated research: 
So, I remember we were both listening to this [Radiolab], and were like, 
that’s really cool, you know? But we didn’t really know how feasible it 
would actually be, like it’s not legal in the United States, how am I gonna 
get this? … So I started doing a lot of research, and realized that it is 
feasible. And with a little persistence and looking into things, and a lot of 
contacting and reaching out to the Facebook group and the Yahoo! group, 
I got some feedback from people and wanted to do it. 
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For Shelly, too, it took more than a listen: 
So, I had heard about it, the Radiolab show, with Jasper Lawrence, and I 
had heard that incredibly compelling story, I can still remember where I 
was when I heard it, I was just like wow, wow, really!? 
… 
Well, that was years ago, but it stayed with me all that time. So, I think, at 
a certain point when I was thinking, [the current drug treatment’s] not a 
permanent fix, I don't wanna be on that forever, that I started turning to 
that. 
 
Still others, like two young women in their late teens being treating with 
biologics for Crohn’s disease, told me that they had not heard of helminthic 
therapy before I brought it to their attention. They sounded uncertain about 
trying it, and the yuck factor was big, but though it would be a last resort for 
them, like many other patients they felt that if the potential benefits outweighed 
potential risks, it was worth a try. 
Why did hookworms really catch these patients’ attention? Tori said: 
Many times a pill they say is not going to do harm, does harm, after 
several years of observation of people taking certain medications. So, I 
actually would stick to the worm. They’ve been around longer and we’ve 
been working together longer than some manufactured medication. 
 
She added that personality may also play a role in turning toward helminths: 
But many people, I think, I are conformists. And they want to go the 
medical route because that’s what is accepted, and that’s all they are open 
to. And there’s a few of us that are maybe rebels for whatever reason and 
we … I think it’s a certain character personality character trait that keeps 
people like myself searching and looking for other alternatives and 
learning about things. Because if it wasn’t from my research skills and 
learning, I probably wouldn’t be taking helminths. But there’s that 
element of my personality that keeps me open to new ideas. 
 
Greg spoke about how new generations are less likely to trust doctors: 
There’s generational differences with how people trust doctors, too. Like 
the older generation, they’ll just do whatever the doctor tells them to. Like 
my mom, she just, she won’t ask any questions, she won’t bring up 
anything, she won’t do, cause they act like the doctor’s god. 
 
Patients often felt like they were on their own in discovering helminths. Hugh 
told me: 
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I had to go through six GI [gastro-intestinal] doctors before I found 
somebody who would accept. Just, a lot of them don’t keep up with 
current research. They only believe what they learned in med school 20 
years ago. A lot of them are closed-minded, they’re arrogant, they think 
they know best, and they refuse to listen to the patient. So, really good 
doctors are rare.  
 
Tori recalled feelings of frustration when dealing with one doctor who was not 
supportive of her seeking alternatives: 
I had a doctor, when I was 18, when I was sick, really quite sick for the 
second time, tell me that diet had nothing to do with it, and that I could be 
on a jelly bean diet and have a 30 percent chance of going into remission—
that diet had nothing to do with it. I don’t know how any doctor could say 
that diet has nothing to do with your health. 
 
Only one person I talked to heard of it through a friend, and none heard of it 
through a doctor. How people heard about the worms, in other words, was not 
through in-person networks, but through publicly available media and internet 
articles. People are hooked into a network of information that mediates our 
relationships to other parts of the world, to knowledge, and to our own bodies. 
This information network will have an impact on how we react to worms. But it 
also means that some people are out there seeking out information on their 
health, taking an active role in medical research, and looking to the actions of the 
worms, scientists, and anecdotes, and studies rather than just passively receiving 
information from friends, doctors, or television. The role of internet, and its 
flattening of expertise, features prominently. 
 
2: Overcoming the “yuck” factor. 
Self-infecting with hookworm can be a moment of revulsion or optimism. It 
goes against accepted notions of health. As an object of social taboo,6 hookworm 
infections became disgusting and outside of the human realm: an other to be 
expelled or killed, not necessary to life on earth. The social taboo that is 
commonly associated with hookworm is “the yuck factor.” This term is often 
                                                
6 Social taboos may be viewed from a number of different angles. Freud (1913) discusses them in 
Totem and Taboo as a social creation. A Foucauldian (1990 [1978]) view might be that social taboos 
and repression are another way for us to reinforce the prominence of the matter at stake. 
Agamben might say that bare life is an expression of taboo, and that the object of taboo becomes 
expendable. All of these makes sense in terms of coming into contact with the hookworm. 
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used loosely by hookworm users, but scholars have been debating its meaning 
specifically in the context of biotechnological innovations since 1997, when 
bioethicist Kass published an article called “The Wisdom of Repugnance.” 
Niemelä (2011) asserts that Kass’s theory—that the yuck factor is based on a 
“deep wisdom” of moral disgust—is damaging because it justifies a moralist 
approach to biotechnological decisions such as stem-cell research. Instead, they 
propose a yuck factor based in folk biology. Folk biology is how people use 
everyday perception and cognition to sort out their material observations. For 
example, since we need sex to reproduce, and cloning doesn’t include sex, it is a 
disgusting way to create new life.  
The yuck factor is an ideal example of affect building relationships between 
human and hookworm are built. The yuck factor is not an essential characteristic 
of parasites, but rather a hegemonic, material-semiotic construct, capable of 
being changed. Hookworm became disgusting probably through a combination 
of new research on the germ theory of medicine and the hygiene movement that 
followed it; racism and the discursive association of worms with poverty and the 
diseased other; the negative effects of hookworm that people experienced, such 
as anemia, itchy rashes, and stomach pain; and the association of snakes with the 
fall from the Garden of Eden. For Dixie, 
You know, I’ve been looking at this for a very long time, and I am a 
religious person, and you can find references to nasty parasites in the 
bible, and that’s how far back our history goes. Like snakes, people are 
just averse to worms…. We have aversions to things, and probably there’s 
some basis for that in evolutionary biology. 
 
The yuck factor identified as a reason helminthic therapy is rejected by some 
individual patients, according to some articles (Kaplan 2009) and to internet 
social media sources. It’s also the reason that all of my interviewees must remain 
unnamed—even a wholly legal hookworm infection could get someone in 
trouble with friends, family, or workplace. Jill wrote, 
I’ve only told a couple of very close family about it. Having read tales of 
woe on forums about people getting horrified reactions I thought I’d leave 
it until I (hopefully) see results so that it becomes easier to explain. I went 
to my GP [general practitioner] to talk about it and get blood tests before 
inoculating and the locum I saw (who I’d never seen before) said, “I don’t 
know why anyone would want to put that in their body,” and made me 
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make another appointment with the practice nurse rather than taking 
blood herself. 
 
When I began my research, I thought that my patients would tell me that the 
yuck factor very difficult to overcome. However, it turns out that the affect of the 
hookworm cuts both ways. As it heals people, their disgust falls away. Jill said 
that she “got over that within minutes of reading about the potential benefits.” 
Ann told me, 
Changes with taking one of the biologics could be permanent. So I kind of 
weighed the pros and cons of each. I wasn’t really grossed out about that, 
I was more like, cause I knew it’s not like you eat worms or anything gross 
like that, but I had reservations still. But I felt like it was the better option 
for sure. 
 
Molly, a Crohn’s patient who was not using helminths and had heard about 
them only from me, indicated that the yuck factor was certainly present, but 
could be overcome. She used naturalness as rationale: 
I was talking to my parents and my boyfriend about it, and their first 
reaction was like, oh my god, that is disgusting. And that was my first 
reaction, too, like I would never do that, and then I thought about it more, 
cause I guess in like an illness you can kind of dismiss something for no 
valid reason, so I looked a little more in depth and made my decision on 
this. … Yeah, it kind of freaked me out, because I guess my thoughts were 
at first, letting that into your body... it’s natural, but it doesn’t seem 
natural, cause you’re not like born with that naturally, but it’s natural 
compared to the medication you’re putting in. 
 
Overcoming the yuck factor sometimes takes place within a generational 
divide. Greg, for example, grew up the Southern US. His grandmother was 
adamant about good hygiene and avoiding parasitic worm infections. Her 
generation, after all, was the one born just after hookworms had become a public 
enemy and widespread eradication efforts accompanied a new conviction that 
hygiene was highest good (Rockefeller Sanitary Commission of Hookworm 
Disease 1911). However, today Greg reinfects with worms at least once a year in 
order to keep his extreme allergies at bay.  
Negative reactions can be frustrating. Tori said, 
I don’t find it yucky. If anything, I find it, um, natural, to a certain degree. 
Like we’re a part of nature, and we coexist with other beings. … But it is 
disappointing when you speak with someone who you think you could 
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help them, and the idea with parasites, they turn up their nose. And you 
think, well, this could help them, but they’re not even open to that. And 
you think, it’s sad. 
 
Even in conversation with individuals without a diagnosed immune system 
disorder, people’s disgust would transform into curiosity and acceptance 
quickly. Our conversations often ended with questions about the cost and 
availability of helminths. I expected that the stigma around hookworms would 
be much more powerful than it turned out to be. Hookworms’ acceptance by so 
many others, the intrigue of the largely forgotten human microbiome, and even 
the bathroom humor surrounding hookworms may all have contributed to this 
quick turnaround, but most of all it’s hookworms’ effectiveness that changed the 
conversation from “yuck” to, as Ann put it, “it’s cool!”  
Its less a matter of people overcoming the yuck affect—which implies that the 
yuck continues to exist—than it is of them rewriting, or, as Deleuze and Guattari 
(1987) might put it, reterritorializing, the folk biology of the human gut. One 
woman I interviewed got a tattoo of her parasite. Greg is proud when he shows 
off his hookworm rashes (see figure 7). Hookworms, which are presented in 
textbooks as being scary and disgusting, Tori now refers to as her “pets,” and the 
term parasite is discarded in favor of helminths or symbionts by many of my 
interviewees.  
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Figure 7. Greg shows me his hookworm rash. 
 
3: Acquiring helminths, facing the law. 
It has the irony of a Twilight Zone tragedy: if the presence of hookworms 
precludes autoimmune disease, then hookworms will be easy to find only in the 
places where they are not needed. In addition to the evolutionary rationale of 
this situation, it also emerges from drug regulation laws, the pathogenic status of 
these parasites, and the expense of the treatment. The affect of a store-bought 
drug delivered in a tidy package with official FDA approval is very different 
than that of the semi-legal hookworm, and inhibitive to some people, but others 
who seek hookworm succeed in getting it—and may even grow closer to the 
parasites because of the process involved. 
Patients in the US especially have trouble accessing worms, because laws 
about experimental drug use are decidedly stricter here. Hookworms and other 
helminths were determined in 2009 by the FDA to be a biological drug. They 
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cannot be bought or sold in the US. The FDA website states the following on 
their import laws page: 
Hookworms, Whipworms, and their eggs, and larvae used as 
immunomodulators to treat patients with allergies, asthma, autism, 
Crohn’s Disease, multiple sclerosis, Sjorgrens Syndrome, and Ulcerative 
Colitis by deliberate self infestation are considered to be biological 
products as defined in Section 351 of the Public Health Service Act. Entries 
have been declared for personal use only and are accompanied by a US 
Physician’s prescription (FDA Import Alert 57-21 2011). 
 
The FDA’s stance has an impact on what types of people are willing to make 
their way around this regulation, even if the way around is completely legally. 
Ken recounted a conversation with his helminth provider: 
people who do the treatment are way more likely to be anti-authoritarian 
or just someone who doesn’t respect the idea that comes from authority 
figures, just because the authority figure has said it. I think it’s just like, a 
psychological type [of] person. Some people are more into order and 
structured… like they think that laws should be respected, otherwise there 
would be chaos. I guess that’s their line of thought. Other people are, well, 
I think that every situation, every idea should be reconsidered on its own 
merits. … The law and order of “You shall not use this unless its been 
FDA approved”—you have to have some disregard to do it.  
For Greg, it didn’t matter that the drug was untested, and he didn’t mind 
confronting the authority of the FDA: 
No I didn’t even think about it. … I’m not afraid of experimenting on 
myself a little bit, because of my desperation. Yeah, desperation’ll make 
you do crazy stuff. In this case it just worked. … I got real lucky. It could 
have been a complete nonsense thing. It could have been the wrong 
parasite, or it could have been gut flora that does it entirely, not 
helminths. Or a combination of the two! It could have been an interaction 
between gut flora and… nobody knows yet! 
 
At the time the FDA outlawed parasite sales by private companies, the US 
was hosting ongoing clinical trials of whipworm, and at least one private 
company was selling whipworm and hookworm out of Santa Cruz, California. 
This company, now called Autoimmune Therapies, is run by Jasper Lawrence. 
The FDA promptly raided his house in 2009. He now sells helminthic therapy 
from the United Kingdom to patients who can fly overseas. 
Lawrence is the first do-it-yourselfer to procure worms and use helminthic 
therapy outside of a medical setting (J.A. Turton was the first. He infected 
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himself to study hookworms as pathogens and was surprised when his allergies 
went away (Turton 1976). Lawrence is not trained as a doctor. He’d heard about 
helminths and immunology, was desperate for a cure for his allergies, and 
sought out hookworms the old-fashioned way, in his case by mucking around in 
human feces near a designated bathroom area in Cameroon. Once seriously 
disabled by allergies, asthma, and the accompanying immunosuppressant 
prednisone treatments, Lawrence was suddenly better, and with minimal side 
effects. He began selling his own stock of hookworms out of his home by 2006, 
and produced helminths for three years before the FDA stepped in (Adams 
2010). 
Lawrence’s patients must now travel abroad for worms. It’s not illegal to do 
so, but it does cost $2,000 to $4,000 out of pocket for three years guaranteed 
infection—and that doesn’t include the international plane ticket. The leading 
pharmaceutical immunosuppressants cost about $14,000 for a year, or $43,000 
over three years, though with insurance that price becomes affordable. $3,000 for 
worms can be prohibitive for some, but for some as desperate as Greg,  
Like $3,000, whatever. I don’t even care. It doesn’t even matter. I mean if 
this guy turns out to be a fraud, I didn’t even care. It was like, so what? I 
mean I’m not gonna be around to pay this bill anyway [if it doesn’t work]. 
 
One donor, Ronald, said that he didn’t want to have to go all the way overseas to 
get the treatment. Luckily for him, travel overseas isn’t the only way to become a 
“parasite pirate.” Some users set up home cultivation labs so they don’t have to 
rely on the overseas providers, travel, and so that they can remain infected for 
the cost of their home lab, which may include a quality microscope, a foam 
cooler, and Petri dishes. Biologically, a human host can produce 30,000 eggs per 
female hookworm per day. Some individuals even become hookworm egg 
donors, sharing their hookworms’ offspring with others in need who can’t afford 
the multi-thousand-dollar price tag. People can network and discuss hookworm 
acquisition, cultivation, hosting, and sharing online. The Internet has played a 
huge role in people’s ability to find hookworm, with many messages in 
networking groups on the topic of how to acquire helminths. Hugh said 
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It’s not that difficult…. You need a microscope. You can get vermiculite or 
something else. But yeah, I know a few people who did it on their own. 
And they just couldn’t afford it. So, they got it from people that paid for it, 
and… … Now that we have modern plumbing, you really are completely 
safe. 
Jill, who lives in the UK, wrote the following in an email: 
It didn’t take too long, however, to work out just how expensive obtaining 
worms would be from the two “official” providers, and at that point I had 
to discount it as an option. My condition is not in any way life 
threatening—it’s an inconvenience and a discomfort, but I’ve lived with it 
for nearly 30 years, and to me, it’s the norm. I just wasn’t desperate 
enough to spend thousands of pounds on an experiment that may not 
provide the results I hoped for. The turning point came when my 2 year 
old daughter was diagnosed with a nut allergy. We now have to avoid 
any exposure to nuts and have Epipens with us wherever we go in case of 
anaphylaxis. I thought that if I could find a donor to experiment with 
helminth therapy on myself, there could be the potential to treat her in 
future. I posted a donor request on the [internet] forum and was very 
fortunate to get a response. 
 
According to an informational sheet about helminthic therapy posted in an 
internet group, there is at least one helminth provider that will not deny 
helminths to anyone due to a clear lack of ability to pay. Besides, Jill may be in 
for an easier time in the future, since a new hookworm provider, 
Wormswell.com, will be providing 25 hookworms by mail for $200 to any 
address (excluding US addresses). Though US citizens may still struggle to get 
worms, the culture of helminths is characterized by this kind of sharing, open-
source attitude, with an open-source wiki, information- and article-sharing, and 
the hookworm donor culture.  
All of this shows that the material conditions for people to acquire 
hookworms are present. The type of people who will use hookworm are 
becoming averse to law, but are not necessarily coming from an alternative 
medicine perspective. Reaching out for hookworms comes from a combination of 
patients’ desperation and hookworm’s effectiveness (see also step 0), their own 
perseverance, the willingness of other humans to help them out, and finally the 
availability of worms either from commercial providers or DIY hookworm 
donors.  
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4: Contact, mutual conditioning, and the production of difference. 
We have now watched patients become alienated from hookworms, only to 
rediscover them, ask questions, do research, and seek them out. Now, at last, we 
are at the point where the patient actually applies the hookworm to their skin. At 
this point, a number of biological changes take place in both a hookworm and a 
human. I consider the most important affect in the human–helminth relationship 
to be the impact on feelings of healthiness and sickness on the infected human 
body. The production of difference relates to the ways in which animal bodies 
are rendered different from others of the same species through an affective 
relationship, because of contact (or lack of contact). 
In an outdoor setting, hookworm would be doing its part to make this contact 
happen. After being excreted into soil, non-infective hookworm eggs transform 
into infective larvae that can migrate up to 4 feet in soil, which is why regulations 
call for latrines to be dug at least 6 feet deep (Rockefeller Sanitary Commission 
for the Eradication of Hookworm Disease 1911). These larvae, after they make 
their way up to the surface of the soil, wave around in the air in tandem, 
reaching for any contact with human skin that would allow them to move into 
the body. Their chemical senses at this stage are already attuned, so they will be 
able to sense when they are near a human being. In a lab setting, the hookworm 
eggs are cleaned from the feces, counted so that infection occurs in the right 
number, and applied to the skin once they reach the infective larval stage. A 
bandage is then placed over the spot of infection, and the larvae burrow into the 
skin, molting an outer layer as they go and discarding it, turned inside-out, 
wedged into the surface of the skin.  
The area will soon become incredibly itchy, sometimes for months, due to our 
immune system’s too-late inflammatory reaction to the invasion. In the mean 
time, the hookworms make their way through the bloodstream to our lungs, 
recognizing when they get there, again, with astute senses that tell them they are 
being squeezed into smaller capillaries. They moving into the lungs and migrate 
up the windpipe, at which point a human will get a bit of a cough. If the human 
swallows any phlegm coughed up instead of spitting it, these hookworms will be 
successful, and travel down the esophagus and into the stomach and intestines. If 
they are spit out with the phlegm, their lives are over. Hookworms who 
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complete the journey can then mature into male of female hookworms. The 
females can produce up to 30,000 eggs per day. The human host becomes a 
powerhouse of hookworm production.  
Over hookworms’ three-to-seven year lifespan, they both stimulate and 
modulate the immune system. People with helminths live with a constant 
immune response. However, hookworms secrete proteins in the body that don’t 
just keep blood flowing to their mouths, but that also bind to human’s natural 
killer immune cells—the same ones that cause so much inflammatory damage in 
autoimmune patients (Hewitson, Grainger, and Maizels 2009). It is in the 
hookworms’ best interest to call off the natural killer cells. Each hookworm will 
adjust its release of chemicals according to the specific chemical balance within 
an individual human being. 
Just as helminths can harm or heal, they can also cause both painful and 
pleasurable side effects. According to internet forums and helminth users’ blogs, 
negative side effects may be experienced intermittently for the first 90 days of 
infection. “Worm flu,” may include headache, nausea, diarrhea, fatigue, vertigo, 
and more. The primary positive side effect is a feeling of euphoria, also called a 
“bounce” or “hookworm high,” which lasts for a few days after taking the 
helminth. The hookworm high is associated with high energy and focus and 
sometimes extreme relief from the immune disorder being treated. Ann, who had 
infected not long before I interviewed her, told me that 
The first couple of days, I felt really good.… But now I’m in the perfect 
storm of the side effects. 
 
Dixie prefers helminths because  
 
the only side effect is gastrointestinal distress that is self-limiting and 
stops after a while. 
 
Still, hookworms might not always settle well for everyone. Molly, who hadn’t 
tried hookworms, told me “I’d always think that something foreign was inside of 
me.” This could, of course, change if she were to self-infect. 
People around the world who are not purposely self-infecting and looking for 
the symptoms will often not notice the hookworms’ migratory process (except 
for the rash, called “ground itch”). Even patients who self-infect often don’t 
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know where their hookworms are in the journey. Still, these patients do make 
guesses. For Ann, following the hookworm melded with following her body’s 
rhythms: 
 
It’s hard not to, like… maybe I have a touch of being a hypochondriac, but 
that’s what you’re like when you have a chronic disease, you’re always 
monitoring your body, but more so that way now, because I had a little 
cold for the past couple of weeks, and I was like, oh, maybe that’s the 
hookworm migrating to my lungs, and I’m coughing them up, and they’re 
going down. 
 
As the hookworms settle into humans’ guts, these individuals change one 
another. The hookworms will themselves act differently depending upon their 
host, an important side hookworm affect changing in accordance with the human 
host, and feeding back to hookworm. Patients were skeptical about the taking the 
liveliness out of the hookworm. For Molly: 
I guess if they were just found versus in a lab setting, I’m not sure that the 
lab one would have the same effect as the found ones.  
 
For Hugh: 
I just really don’t think they’ll be able to turn it into a pill, I really don’t 
think that’s possible. It’s like saying all right, let’s kill all the bacteria in 
your gut, and turn it into a pill that you take that will reproduce the 
effects of the bacteria, well that’s impossible. I mean there’s a lot of 
research happening with microbiome right now. 
 
For Shelly: 
I think in the case of the worms, there’s this whole sort of feedback going 
on, where they’re sensing what they’re picking up comes through your 
body and adjusting their chemistry accordingly. … Just the whole idea of 
helminths and humans, it’s just like a symbol of that whole thing of not 
understanding the complexity of systems, you know? 
The change that doctors, patients, and the media get most excited about is the 
difference produced in a person’s health. Many interviewees spoke to the 
powerful changes. Tori said, 
They saw what I looked like and the symptoms I have, or had, and then 
they saw me on helminths, and what I huge change it is. So there’s no 
denying that change. You can’t deny the obvious physical health that I 
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have now. So people that know me, they’re like wow. And even friends 
will say, “Are you still taking your pets or your parasites?” and I’ll say, 
“Yes.” 
 
For Greg, the changes were profound: 
I think it’s just from not being sick, and not taking the medication all the 
time. I was very negative, very, very, very. I was, just like disaster-
preparedness-doomer negative. And I’m still a little bit disaster-
preparedness, but reasonable levels. 
 
Shelly also experienced a bit of a personality change: 
Just thinking about the effect of your gut bacteria, your partners down 
there, on your mood and personality, is pretty mind-blowing, which is 
why I was given a little bit of pause with the helminths in that I’ve always 
had a pretty sunny disposition, and never had depression issues or 
anything like that, and am I potentially affecting my mood here? And 
now, I might be feeling even lazier than...! Cause it’s just like I’m on a little 
drug here, like, “Yeah, whatever, man!” 
David, an Australian, was wary of his own need for helminths, but still 
acknowledged their powerful effect: 
But they dropped away after six weeks, and my second dose was a couple 
of weeks late, and in those two weeks I went straight back to where I was 
before I had the worms, so I could feel that, um, you know, that extra level 
that I’d gained ... whilst the worms were actively working in my system, 
so that’s a dependence, and I don’t actually think it’s natural to have that 
dependency…. 
 
Ann mentioned that sometimes it’s not just the positive changes that matter in 
helminthic therapy, but the mildness of the changes compared to 
pharmaceuticals: 
You can get rid of the parasites if you need to. It’s not going to 
permanently change your body unless you want it to. 
 
5. Conclusion. 
Learning to be affected by hookworms isn’t about the hookworm as an agent 
influencing the human as an object. It’s about the relationships that develop 
between human and hookworm inside and outside of the gut. These 
relationships crystallize over and over, and differently each time. Some of the 
basic steps are discernable, though never temporally orderable. They include 
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partings, meetings, and psycho-physio-social changes. The steps incorporate 
human intention, but also hookworms that seek a home, news articles that cause 
an excess of excitement, and drugs that stop working. 
In showing how humans learn to be affected, this chapter shows the 
possibilities for the development of new, experimental therapies, in spite of the 
“yuck” factor, in spite of the lack of encouragement from doctors, and in spite of 
conclusive clinical tests. Instead, material engagements provoke outcomes that 
are more than the sum of these material engagements. Recent human–hookworm 
engagements waver between the inside and the outside of the dominant 
framework of good, tested hookworm and bad, wild hookworm. The many guts 
that are rendered different through molecular exchanges and becomings are one 
of those “minoritarian spaces” that serve as a reservoir for “creative possibilities” 
(Whatmore and Hinchliffe 2010, 452-453). In the next chapter, I expand this 
theme. I move from how hookworms’ affect operates in the lives of patients as 
they learn to be affected, to how hookworms’ affect may influence and interact 
with medical institutions and do-it-yourself practice. 
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CHAPTER FIVE: HOW HOOKWORMS BECOME  
A PART OF INSTITUTIONAL MEDICAL PRACTICE—OR EVADE IT 
 
The material world is not a passive background for human socialization, but 
itself a part of that socialization. By considering hookworms—a part of the 
material world, to be sure—as social agents, their role in the life-and-death game 
of institutional medicine becomes clear. This is not to take power out of the 
hands of humans and say that only the affect of the helminths can decide our 
future. Rather, it is to say that helminths play a role, and must be considered 
when studying the medical industry. 
People who are concerned with helminthic therapy face several challenges: 
Should they press for clinical trials faster? Should they entrust helminthic 
therapy to pharmaceutical companies at all? Should they focus instead on the do-
it-yourself hookworm culture that is springing up? Hookworms open up 
possibilities, both for institutional medicine and for noncompliant patients. They 
walk the line between public health hazard and natural medicine, between tricky 
animal and promising new pharmaceutical. Through a synthesis of narrative, 
interview and ethnographic data, and field notes, I show below the multivalent 
way that hookworms interact with vernacular and institutional medicine. In 
particular, in some ways they are a perfect fit as one of the first in the next 
generation of biological medicines—aiding incorporation into institutional 
medicine. In other ways, they are far too wily to be subsumed—discouraging 
incorporation into institutional medicine. I propose that although hookworms do 
not make a choice about whether they aid or discourage, they do set the stage for 
the decisions that we end up making. 
 
Hookworm Aids Incorporation 
Hookworm bodies subsumed. Human and hookworm are directly involved 
in the production of capital. Host and parasite play out a role that subjectifies 
them as exploited producers for the medical industry. 
Hookworms engage in producing the actual molecules that are now being 
sought for their immunomodulatory abilities. Each hookworm manufactures 
these chemicals for its own wellbeing. It is this process that the pharmaceutical 
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industry seeks to capture, if possible. Some researchers believe that the molecules 
produced by helminths can be isolated and turned into a replicable pill, 
conferring the benefits of the hookworm without the public health hazard of a 
reproducing infectious organism (Harnett and Harnett 2010; Ruyssers et al. 2008; 
Hewitson, Grainger, and Maizels 2009). Pill form would be preferable for 
pharmaceutical companies because it would take away the air of public health 
risk that surrounds helminths. Helminths themselves would not exist, and 
therefore it would not be possible for them to reproduce on their own. It would 
also ensure that the chemical compounds were all exactly identical, and that the 
patient would get no more and no less of the compound than desired. As Dr. 
Weinstock told me, tested and approved drugs need to be identical, like the 
bottles of aspirin you can find in any drug store across the country. If helminthic 
extracts became a reality (as crude versions already are), helminths themselves 
could be eliminated, their work done and ready to be monetized. 
The hookworm’s body could play a double role, since it is not just a producer 
of a commodity—its special immunomodulatory chemicals—but also itself a 
commodity. According to some researchers, the parasite’s chemicals will not be 
likely as effective as an extract. Bilbo et al. write,  
First, it is difficult to imagine a single pharmaceutical or even a collection 
of pharmaceuticals that could recapitulate the vast complexity of the 
interaction between helminths and the host immune system. While 
pharmaceuticals are generally directed at one component in the immune 
apparatus, a single helminth species produces dozens if not more 
molecules that each target specific components of host immunity…. Not 
only is the helminth/host interface vastly complex, it requires continuous 
input from the helminth…. Natural selection has tested countless billions 
of combinations of molecular tools over millions of years, selecting those 
that are most effective for both helminth and host survival. Quite 
obviously, no pharmaceutical has ever been developed to match that 
record (2011, 500). 
 
If pharmaceutical companies are able to harness parasites’ healing abilities, 
and especially if they are able to control the means by which hookworms 
reproduce—i.e., only in a lab and on the command of an expert—they will be 
able to sell the parasite body itself. Successful trials, such as a December 2013 
trial showing whipworm to improve autism symptoms (Thompson 2013) show 
strides along this path.  
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Hookworm, if successfully domesticated and made replicable and profitable, 
will become further engaged in capitalist processes by its role in the stock 
market. Like other pharmaceutical drugs, helminthic therapy has the power to 
bolster and crash a pharmaceutical company’s stock. No clinical trials have yet 
been attempted on hookworm in the US, but pig whipworm is being tested for 
everything from Crohn’s disease to autism, according to ClinicalTrials.gov. One 
company, Coronado Biosciences, was involved with a high-profile Crohn’s 
disease trial using pig whipworm. It failed in October 2013, causing Coronado’s 
stock to plummet 67 percent (Weintraub 2013). Three of my interviewees owned 
stock in the company. When asked if he thought helminthic therapy should 
remain non-monetized, Hugh said 
 
I wanna make money! And there’s no way, obviously it’s not my idea, I am 
just investing in a company. No, it’s gonna be a drug, just like anything. 
 
Word in the internet forums is that Coronado Biosciences is simply regrouping 
for another trial, one that will hopefully be more successful—the proof they point 
to is how the company’s CEO bought $114,200 worth of shares in January 2014. 
Even before the animal is approved for sale—in fact, even when it fails—it is 
sopping up funding and generating activity in the world of speculative capital.  
It goes deeper, too. Cooper (2008) writes that the biotechnology is seen as a 
solution to economic crisis that is also supposed to push back the limits to the 
growth of capitalism. Economic production is relocated at the “genetic, 
microbial, and cellular level, so that life becomes, literally, annexed within 
capitalist processes of accumulation” (19), even displacing the primacy of 
geopolitical relations. 
Hybrid experiments. The hookworm is not actually a laborer, since it doesn’t 
receive monetary compensation. However, within the human body, hookworms 
may become part of a hybrid system of the social reproduction of health. There is 
a hidden role that human bodies—often with helminths inside them—are 
playing for the medical industry. This hidden role includes producing new 
knowledge about medical treatments; producing more hookworms for use by 
pharmaceuticals; and producing healthy bodies that are able to continue regular 
human labor.  
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Human bodies are targets for monetization as subjects of medical 
experimentation. Pharmaceutical companies have long found the Global South a 
plentiful source of bodies for vaccine and other medical testing, with few consent 
procedures and subjects for whom tests may be their only shot at medical care 
(Shah 2006). But the same thing is happening, if more quietly and willingly, in 
the US (aside from disasters like the Tuskegee syphilis study). The US economy 
remains in need of economic development, and it is not afraid to enroll US 
citizens to this end (Cooper 2008). People in the US make the perfect bodies for 
new drug experiments on autoimmune diseases because these new diseases are 
emerging primarily in people with particular microbiomes and diseases 
consistent with “more developed” regions. This is not to say that medical 
experiments don’t help people, or that clinical science isn’t valid. However, 
bioscience and capital are co-constituted in the creation of conventional medical 
knowledge. Unlikely alliances like that between early HIV/AIDS patients, 
libertarians, and pharmaceutical companies are an example, and hookworm use 
could be another example. 
Postgenomic medicine addresses factors outside simple genetics—such as 
ecology environment, and within that, microbiome diversity—in understanding 
lasting effects to a person’s health. Finding the right combination of human 
subject and living postgenomic treatment requires a lot of trial-and-error. When 
trial-and-error is a concern, clinical trials that must be refined and repeated over 
and over can become expensive. Crowdsourcing medical data in order to define, 
through anecdote, appropriate hypotheses and new potential medicines, is an 
up-and-coming exercise. Pharmaceutical companies are already beginning to 
reverse the usual lab-to-market flow, in which lab experiments, often on animals, 
then go to clinical trial and finally to the public market. Instead, they are first 
collecting data on the public use of both regulated and unregulated drugs from 
websites such as PatientsLikeMe.com and Crohnology.com, as well as 
conducting surveys among internet forum participants. Using this crowdsourced 
data, they can then cultivate innovative drug ideas, examine possible 
combination of drugs, and follow emerging side-effects that may point to new 
uses for an old drug (Cooper 2014). Cooper describes this as part of the radical 
end of the translational medicine spectrum. Translational medicine is about 
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“translating” medical knowledge from the lab to the clinic in order to more 
effectively and quickly get people treatment and drugs. When taken this far in 
the hands of drug companies, it can actually take the experiment out of a lab 
setting, instead encouraging individuals at home to experiment with 
unapproved treatments, or with drugs that are approved for a completely 
different use. Indeed, there are good reasons for the FDA, whatever it’s debatable 
ties to the drug industry, to maintain control of helminthic therapy in order to 
protect citizens. The side effects, and their frequency, are unknown. There are 
anecdotes of increases in autoimmune sensitivity after helminthic therapy is 
discontinued. As one helminth provider put it,  
Healthcare and medicine are the most highly regulated markets in the 
world for a reason. The consequences and costs of getting it wrong, and of 
cretinous rip-off artists, are really high, not just in terms of the damage 
they can do if their therapy is actively damaging, but again, the 
opportunity cost of not using an effective therapy—and instead using 
some bullshit one—could be enormous. 
 
Dove et al. writes that biological citizens are “entrepreneurial citizens who 
are autonomous, self-governing and increasingly conceptualizing themselves in 
biological terms and ostensibly taking responsibility for their own health” (2012, 
5). Like the case of Mansfield’s seafood, responsibility for health falls onto the 
backs of the public. However, unlike Mansfield’s seafood, this risk is not only 
willingly taken on by citizens, it is often demanded. As during the AIDS 
epidemic, autoimmune disease patients have become desperate for something 
that will work as they build resistance to the drugs available. This “biological 
citizenship,” or desire to self-experiment for the greater good, “is accompanied 
by the rise of patient advocacy and health activism (Dove et al. 2012, 5; see also 
Cooper 2008; Rose and Novas 2004).  
Ironically, the human subjects who acquire hookworm in an underground 
economy or cultivate them at home outside of the commodity network are also 
contributing data that may ultimately help make parasite drugs standardized, 
more socially acceptable, and more easily available, at least to some. As Cooper 
asserts, the questions have now become, “By what right, then, do pharmaceutical 
companies retain the sole privilege of intellectual property over an experiment 
that has been so rigorously outsourced?” and, how will “the unknown, visceral 
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risks of self-experimentation return in the form of speculative profits and 
inaccessible drug prices” (2014, no page)? The corporate-state is starting to admit 
that its methods of laboratory science need to be shifted to use the innovations of 
breathing, creative, contingent life to its advantage. This crowdsourced data 
brings “to the fore the political determinants of health, together with the 
attendant social and biological determinants” (Dove et al. 2012, 9), and uses them 
for profit. 
The do-it-yourself and underground hookworm community fits this profile. 
They are readily willing to share their experiences with researchers and other 
patients online, and don’t see their information sharing as an activity that should 
be compensated. Yet some of them see problems with the way that the 
pharmaceutical industry works. Tori said, 
We know that if you read historically, many times a pill they say is not 
going to do harm, does harm, after several years of observation of people 
taking certain medications. So, I actually would stick to the worm. 
They’ve been around longer and we’ve been working together longer than 
some manufactured medication. I don’t trust the pharmaceutical 
companies either. There’s too much money wrapped up in it. I’m kind of 
disillusioned with the pharmaceutical business. 
 
Ann said that using hookworm was like “giving an ‘F-you’ to the pharmaceutical 
empire.” When asked about whether we should rely on clinical trials, Sean 
Ahrens, a whipworm user and the founder of Crohnology.com, sent me a link to 
Ben Goldacre’s Bad Science: How Drug Companies Mislead Doctors and Harm 
Patients (2013). Ahrens wrote, 
Yes, real world effectiveness is what actually matters. Disneyland clinical 
trials [that] can be manipulated to show positive data undermine 
credibility of our current evidence base. 
 
People go around the medical industry anyway. Ahrens founded his website so 
that people could share folk knowledge, but also to inspire pharmaceutical 
companies to be more effective: 
Drug companies are horribly inefficient, and the cost of clinical trials is 
causing them industry alarm. They are looking at what we are doing as 
kind of like “Star Trek.” Some of them believe what we are doing is so 
crazy it might just be the key to where the industry goes to actually learn 
about drug efficacy. But it’s so futuristic, and they are so risk-averse, I 
think they relate to us like they are watching a movie. 
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Ahren’s Crohnology.com, like PatientsLikeMe.com, aggregates information on 
patients’ objective and subjective experiences with experimental treatments. 
Crohnology.com features 5,809 users with Crohn’s or another inflammatory 
bowel disease. Of these, as of March 2014, 22 users are on hookworm, 17 are on 
pig whipworm, and 39 have had a fecal transplant to replenish their 
microbiomes with someone else’s gut bacteria. Users can visit treatment pages, 
where treatments like helminthic therapy, special diets, and pharmaceutical 
drugs are ranked for effectiveness, compared to users’ self-assigned, zero-to-100 
“health” rating, and other charts and comparative data (see figure 8). Researchers 
like myself who are not conducting an official study on the site are not allowed 
to access patient questions-answer pages and patient reviews of various 
treatments, but these user-contributed features, plus blog posts and other 
community-building pages, are available for other patients. 
The irony of helping oneself by helping pharmaceutical companies in the 
right direction—corrupt as one may think they are—is inherent in all healthcare 
under capitalism. Healthcare can not only become a market, it also falls into the 
category of social reproduction, or the replication of conditions, like health and 
children, that are necessary to maintain a class-based labor system. As Katz 
writes, 
almost by definition, social reproduction…must be accomplished, and it is 
in the interests of people themselves to ensure this no matter what the 
circumstances in which they find themselves. Thus, the withdrawal of 
support for social reproduction on the part of the state, capital, and even 
civil society will be countered to whatever extent possible by household, 
familial, and individual efforts” (2001, 717-718). 
 
Hookworm, as a tool for the social reproduction of health, inevitably becomes 
part of perpetuating the capitalist system, even when cultivated at home. In fact, 
home experiments with hookworm may be seen as a neoliberal method for social 
reproduction, shifting the tremendous costs of preliminary research off of 
pharmaceutical companies and onto financially and medically unprotected 
citizens (Cooper 2008; 2014). 
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Figure 8. A screenshot about human hookworm therapy from Crohnology.com. 
 
In geography, both Julie Guthman and Becky Mansfield are working on the 
neoliberalization of health. Between them, they look at how bodies are enrolled 
as a type of spatial fix for offloading excess capital and how the individuals 
attached to these bodies are made responsible for any problems that arise 
because of this spatial fix. Mansfield (2012) explores how women are to be fully 
responsible for their mercury intake though careful seafood consumer decisions, 
while the corporations that pollute fisheries are not held at all accountable for 
their ruining an entire food supply. The burden of health falls onto the 
individuals who are constructed as consumers being negatively affected by 
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toxins in seafood rather than on the corporations that put the metals there in the 
first place. Guthman (2011) explains how people with bigger bodies are said to 
be obese and are framed as not taking care of their health under the input-output 
calorie theory of weight gain, when in fact, the blame may fall to a toxic 
environment and toxic foods. Her work focuses on how the body has become the 
site for a new socioecological spatial fix—for the absorption of capital in an 
already saturated economy always on the verge of crisis (under review). 
Hookworm use, whether at home or as part or as part of a new wave of 
monetized biological medicines, can become useful to the medical industry, or at 
least to neoliberal healthcare systems as a whole. However, in some ways, the 
material and affective qualities of hookworms discourage their incorporation 
into either traditional or neoliberal medicine, instead lending themselves to new 
folk knowledges and a gift economy. 
 
Hookworm Discourages Incorporation 
How does hookworm resist incorporation into institutional medicine? In this 
section, I show how hookworms are resistant to being tested and marketed. First, 
however, note that the yuck factor is not one of these factors. As discussed in the 
last chapter, people are sensitive to a range of hookworm affect, not just the idea 
that hookworm is gross and yucky. Although people did have a strong yuck 
response, it was highly flexible and could fade quickly to fascination or rolled 
into “good nature.” Drug companies would therefore have no problems 
marketing the hookworm. This is especially true if they were marketed as 
probiotics or even helminths instead of as parasites: many of my interviewees 
use terms besides “parasite” to present the topic to friends and family. Nor 
would the yuck factor stand in the way of hookworm becoming a popular folk 
treatment. Hookworm does, however, have physiological and lively 
characteristics that cause it to falter in the face of pharmaceutical logic, making it 
difficult to develop. 
First, evolutionary biology is difficult to navigate in labs research. Lab mice, 
malleable as their genes may be, do not provide a comprehensive model for 
immunology because they are so far removed from the kinds of epigenetic and 
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microbiomic contingencies that wild animals, and even humans, experience 
(Maizels and Nussey 2013). 
Second, helminths can be difficult to immediately test in clinical trials. A 
properly designed clinical trial would need to test specific helminths against 
specific diseases. In some cases, a combination of helminths, or helminths and 
microbes, would provide the best treatment, creating innumerable testing 
permutations. The task is even more difficult if researchers wish to get to the 
specific chemical combinations that work for various diseases, since each 
helminth secrets multiple types of molecules to change its human host. Each 
individual human will also react differently to the individual worms, just as they 
do to individual drugs and environs. Add to this how little researchers know 
about the mechanisms through which helminths work. We do not even know all 
of the immunomodulatory chemical compounds helminths exude in the first 
place. 
Research by doctors like P’ng Loke and Joel Weinstock still forges ahead, but 
the going isn’t smooth. When a recent trail using pig whipworm flopped, 
internet forum users speculated that it was because the trial didn’t last long 
enough for helminthic therapy to do its work. The entire trial would have to start 
over. Would the project run into a similar design problems next time? For 
example, Ronald, a forum user seeking a hookworm donor, could foresee long 
term difficulties when choosing pig whipworm over human whipworm or 
hookworm. Human-acclimated parasites are known to last longer in human 
hosts. He told me in a private email, 
There is a company in Massachusetts called Coronado Biosciences who is 
doing clinical trials on TSO (pig whipworm) for Crohn’s disease. TSO can 
only live in the human body for ~ 3 weeks. … Autoimmune Therapies 
guarantees their human whipworm for 18 months, and their human 
hookworm for 3 years.  
 
Another concern is whether pig whipworms would work as well as human 
parasites, and if not, if they would taint helminthic therapy findings. Shelly said, 
But they’re using mostly or possibly all pig whipworm, and that’s not 
necessarily going to be as effective as human. There definitely are some 
worries that I’ve heard from some of these bulletin boards, that the results 
will be bad and it will be unfairly, prematurely… [dismissed].  
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Shelly thought researchers chose whipworm because they were considered less 
of a public health threat: 
I’m sure it will be way easier to get a hold on pig, because their natural life 
cycle is much shorter in humans. 
 
She also worried that certain qualities of the human hookworm would keep them 
from going through testing: 
There’s a lot of speculation in the helminth community that nobody really 
wants to invest in it, because it’s gonna be hard to make money on it, 
because you can ultimately be pooping out eggs and distributing it to 
people, you know! So probably more, the money’s going in there and 
you’ve probably heard about this too, there’s people trying to extract 
whatever chemicals they produce, and make drugs from that. 
 
Another debate within helminthic therapy circles is whether the healing 
compounds of a parasite could be extracted and turned into pill form. Inside and 
outside of institutional medicine, people debate the merits and drawbacks of a 
pill form for important helminth molecules, and whether this method is 
plausible. Even if certain useful compounds could be isolated from a hookworm, 
it might only be helpful to certain people with certain diseases, and then perhaps 
only a percentage of them. A live parasite, on the other hand, with all of its many 
chemical compounds intact and its ability to change its reactions depending 
upon the human microbiome it inhabits, may be more universally helpful (Bilbo 
et al. 2012; Adams 2010). The pill might have no side effects, though more likely, 
it would simply have different side effects than the worm, as we have no way to 
know how a singled-out chemical would react differently from one directly 
secreted by a helminth alongside other molecules. The side effects of this 
biologically-derived drug could be similar to the sometimes dangerous side 
effects of biologics like Humira and Remicade. 
On the other hand, if helminths are taken up by institutional medicine as 
wholes, they will require an animal in which to breed. Their intricate life cycles 
cannot be completely outside their specific host species. For example, a dog 
tapeworm will survive for only about 10 days in a human, while a dog 
hookworm can migrate to the wrong part of the human body. A human is a 
completely unfamiliar ecosystem for these parasites. Likewise, human 
hookworm would have to bred inside a human being. When P’ng Loke told be 
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about the pig whipworm he tests in mice, I found out that the process of 
acquiring them is relatively disassociated with the clinical and lab trials 
themselves. The doctor I spoke to about it would only refer to pig whipworm 
breeding as “good manufacturing practice,” “factory process,” or “industrialized 
process.” What happens when we turn to human hookworm production? What 
would humans look like as part of that hybrid production process? If pigs that 
act as “reservoir donors” for whipworms are part of a factory process, would 
human reservoir donors need the same designation? A similar question arises in 
the case of fecal matter transfers, which went under FDA regulation in July 2013, 
wherein donors must now undergo screening similar to those for blood donors. 
Another important question is whether helminthic therapy is actually going 
to be profitable enough to garner costly clinical trials in the first place. Medicine 
is doing a great job of monetizing other biotech processes, such as cloning and 
genetic testing and modification, but helminthic treatment could be simple and 
inexpensive to manufacture. Ronald wrote about the problem with monetizing 
the therapy: 
I think it has to do with potential for profit. People can propagate their 
own hookworm once they get them the first time. With TSO [pig 
whipworm] they would be dependent on an “expensive” little salt water 
drink every 3 weeks. My first month on Humira cost the insurance 
company $9,600 for the first month. It’s all about money and greed.  
 
All of this shows both how hookworm may prove difficult for corporate 
subsumption and how well suited it is for DIY experimentation. Where human 
helminths may pose a manufacturing problem for researchers, they are relatively 
easy for humans to reproduce in their own bodies at home. Where the flexibility 
of hookworms may cause roadblocks to designing a pill or the pinning down 
cause and effect in lab and clinical experiments, this flexibility makes them 
versatile for at-home users who wish to share with others or who are willing to 
take the scattershot effect provided by helminths as long as their primary ailment 
is treated. 
Do-it-yourself and underground hookworm therapy is a lively movement. 
Whether the hookworm larvae come from a helminthic therapy provider 
overseas or from a donor, people are using them, talking about them, and 
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creating their own economies in the process. From the 
OpenSourceHeminthTherapy.org wiki, which describes how people can breed 
their own hookworm at home, to questions over whether to compensate a 
hookworm donor monetarily, to detailed narrations of individuals’ journey with 
hookworms, to very real donations of larvae-filled feces, the culture is thriving. 
By one researchers’ estimates, the number of helminth users today totals in the 
thousands. 
While hookworms are unlikely to overturn neoliberal medicine, they still 
appeal to an “experimental” or counter-cultural medical knowledge (Davies et al. 
2004). For better or worse, this leaves patients with a series of choices to make, 
and an unclear future for helminthic therapy. In the next chapter, I will argue 
that we can’t rely on any one movement—such as do-it-yourself hookworm 
therapy—to liberate us from the mires of an unjust pharmaceutical landscape. 
Individual’s access to healthcare and lawmaking will remain unequal as long as 
we remained embedded in a capitalist economy. Rather, although hookworms 
themselves do not make stark changes to the structure of the health care system 
in the US, they do give us a chance to rethink the way we see our bodies and 
animal bodies as exploitable, and to shift the conversation that we are having 
away from simply “What can we do to press for a just system,” to “What can we 
do within the context of hybridity (a context we cannot easily alter) to move from 
experiments benefiting neoliberal economies to experiments that truly benefit 
people?” 
 67 
CHAPTER SIX: DISCUSSION 
 
Several overarching themes emerge from my research. In this discussion, I 
move through some of these themes, interpreting them in light of the theoretical 
framework from Chapter Three, and offering recommendations based on these 
interpretations. 
One theme that repeatedly came up in interviews and online was that 
patients are heavily concerned with their place in nature. Many of their 
comments had to do with the naturalness of helminthic therapy and with our 
place in an ancient ecological order. This is consistent with a recent cultural turn 
toward evolutionary medicine. While most people understand that “the natural 
way” isn’t always the most life-preserving—they would agree that smallpox 
eradication was a good thing and that antibiotics are an essential medicine—the 
concept of what is in fact “natural” has undergone a subtle change. To return to 
Molly’s quote from Chapter Four, helminthic therapy is 
natural, but it doesn’t seem natural, cause you’re not, like, born with that 
naturally, but it’s natural compared to the medication you’re putting in. 
 
An infection-free body has, until more recently, been seen as the epitome 
health (Brüssow 2013). However, the definition is changing, and patients are 
leaning on this change, eager to make up for the inadequate explanation offered 
by medical science about their immune disorders (Velasquez-Manoff 2012). Their 
acknowledgement of this new definition of good health can go in two directions. 
On the one hand, in a neoliberal twist, patients may see individuals as to blame 
for their autoimmune diseases, because they or their parents hadn’t been taking 
trips to the microbe-filled countryside. On the other hand, they may express a 
concern with society more generally, as in the chlorination of water, the ubiquity 
of antibiotics in meat, widespread urbanization, or the modern obsession with 
hygiene.  
Will this trend in the fetishization of nature lead to an essentialist ideal of a 
pristine human with an intact, perfected microbiome (Zuk 2013)? American Gut 
(AmericanGut.org) uses volunteers to collect data on the American microbiome, 
while the Earth Microbiome Project (EarthMicrobiome.org), funded by biotech 
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companies, states that it wishes to “characterize the microbial taxonomic and 
functional diversity” of the earth’s biomes. Will this fetishization also encourage 
Westerners to seek a pristine nature from which they have been alienated, 
demonizing those who, with sterile bodies that consume reckless amounts of 
antibiotics, endanger public health? Concepts of nature can shift wildly (Smith 
1984). But these concepts in themselves are not the driving force for change in 
medical practice. Trends in discourse have a material basis. Most of the patients I 
interviewed had tried pharmaceutical drugs first, and compared helminths to the 
drugs. The patients were affected by the helminths for a relational reason, not 
because the helminths had a “naturalness” about them, but because they had a 
positive outcome.  
Concepts of nature are beholden to health, like they are to capitalist pursuits, 
and health has a material basis, whatever direction the term takes. Real ailments 
call out to be addressed, and even though pathologizing an “abnormality” is 
itself based on problematic ideologies (Metzl and Kirkland 2010) good health 
remains subjective and flexible.  
Another theme gleaned from interviews was that patients are generally 
practical. They do not always stay within the confines of a predetermined 
timeline regarding their treatment. Instead, when the pharmaceuticals stop 
working, they seek something else, tested or not, FDA-approved or not. They 
don’t always listen to an official expert, though they take scientific standards 
very much into account. As Shelly put it, 
I find myself being a very, very science-minded and skeptical person. … I 
don’t consider myself someone who’s drawn to alternative medicines. 
 
However, my interviewees did think that we can have a special connection to the 
hookworms, as evidenced by the number of people who thought affectionately 
about the parasites, calling them “pets” and “little guys.” Shelly went on,  
I think it had occurred to me even before the worms, just in thinking about 
how humans came together and, you know—from micro-organisms to 
humans, how we were collectives—but now it feels much more embodied, 
and the, you know, counting these little guys too…. 
 
Patients were conflicted about medical authority. They often believed there was a 
place for the FDA, frustrating though its actions were, but there was also a high 
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level of mistrust of the pharmaceutical companies and doctors, even when the 
development of affordable drugs were seen as a necessary part of long-term 
public health. 
If you measure this science-mindedness and confusion about medical 
authority next to the propensity to affiliate deeply with the parasites, you can see 
how the worms gave rise to multiple angles of association. The politics of 
helminthic therapy is thus materially and affectively derived. Patients are not 
simply following in the path handed them by one particular institution. 
Experience mattered. But it’s not just that experience mattered, it’s that experience 
was mattered. People did not act in accordance with what was safe or what was 
clean, they were driven to act by their physical needs. This is not to reduce their 
actions to a mere response to the physical. People did have a series of decisions 
to make, but they were constrained by the site in which they were embedded, 
one with lively companions who could harm or heal, but one in which they faced 
severe consequences for inaction. 
Human and hookworm are part of a bodymap of relationality (Woodward 
and Lea 161). However, in the case of helminthic therapy, instead of looking for 
affect emerging from the relationships strung between the inside of the body 
(thought, emotion, molecular change, physical pleasure and pain) and the 
outside (other mammals, exciting or everyday events, institutions), we find a 
power in the proximity of the relationship happening within the human body—
between human and hookworm.7 The differences made in mood, physical 
comfort, and political possibilities—the affect—associated with gut health allows 
people to manifest more possibilities for the future of the human body than a 
simplified assumption about human nature, even if that human nature is 
conceived as altruistic. Further, their material actions—the reproduction of a 
worm, a shared microbiome, a happier body—made a bigger impact on Crohn’s 
disease treatments than verbal demands for treatment grounded in ethical 
philosophy, since a philosophy of wellness already dominates this society. 
To illustrate the generative potential of the material and the affective, let me 
convey a couple of scenarios. In one of these speculations, emergence and affect 
                                                
7 The many microbial bacteria living in the gut may be deeply enmeshed with the human–
helminth relationship as well (Walk et al. 2010).  
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are down-weighted. In the other, they are central. Each points to different 
possibilities. First, suppose we consider that our future prioritizes 
representational abstractions like human nature and free will over emergent, 
multi-directional affective relationships that promote health. In the case of 
helminthic therapy, we could imagine some altruistic humans kindly sharing 
hookworms with each other until they are nearly shut down. However, they 
would continue to speak out about the importance of hookworms, and even get 
themselves in trouble by attempting to ensure that everyone had access to the 
animals. Meanwhile, other people might be blaming themselves for their 
sicknesses or looking for someone to blame. If only they’d been less stressed out, 
or if only they’d had the money for a genetic test, or if only they had made sure 
to drink from fresh springs to diversify their microbiomes! Or perhaps it’s not 
the individual who is responsible, perhaps it’s a society-wide neglect of natural 
health! Holding one party accountable is difficult and doesn’t capture all of the 
factors at work, nor does it point toward a noncapitalized way forward. 
Now, let us take an assemblage perspective where the material and affective 
are central. Americans get used to detesting the idea of parasites through a series 
of anti-parasitic hygiene practices implemented in the beginning of the twentieth 
century. However, some of them develop autoimmune disease, in part because 
of these hygiene laws as well as genetic predisposition, personal stresses, and the 
anxiety of advanced industrial society. Some researchers and some citizens begin 
to uncover a particular relationship—the one between humans and helminths—
as an interesting piece of the puzzle, and wonder what can be done to restore it. 
They begin to experiment with helminthic therapy, each in their own ways. The 
hookworms, as explained in this thesis, lend themselves to the do-it-yourselfers 
as well as to the medical establishment, and citizens have a choice about where 
they want to turn for help. If they turn in the do-it-yourself direction, they will 
face a series of challenges: how to cultivate the worms? How to communicate 
with one another and share supplies safely? How to navigate unknown, long-
term side effects? How to support others who are afraid of hookworms, or who 
are too poor to get them? If they turn toward institutional medicine, they will 
face another series of challenges: How to get doctors and researchers on board? 
How to make the worms profitable for pharmaceutical companies? What to do 
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about the difficulty of testing human parasites? The importance, however, is that 
this is not a moral dilemma, where the patients’ job is to convince others to take 
on the burden of fighting against a unidirectional flow of power, but rather a 
place where more open-ended action, whether insurgent or accommodating, can 
rewrite the status quo.  
As these speculations show, assemblage ties together economic, social 
constructivist, and biopolitical theories. All three angles engage one another, as I 
pointed out in Chapter Three. Biopolitics appeals not just to the economy of 
biopower produced by humans and helminths, but also to the imperative of life 
that makes modern medicine sacrosanct. This imperative for health is socially 
constructed, but it’s also the result of material forces, since it is triggered and 
reinscribed by infections and autoimmune diseases that cause pain. Social 
constructions of animal discourse, such as the cute hookworm versus the 
disgusting hookworm, also come from material interactions—a healed body, a 
hurting body—as well as from the literature of capital-seeking businesses like the 
New York Times and AutoimmuneTherapies.com. Even websites such as 
OpenSourceHelminthTherapy.org, a wiki that allows users to share information, 
are formed from human–helminth and human–human relationships, poverty, 
internet access, and a belief in mutual aid, rather than from one aspect alone. 
It would be easy to reduce this human–helminth assemblage to the simple 
idea that everything is connected, but even that perspective is missing out on an 
important element—unpredictability. This assemblage is not merely complicated 
and it is not predictable with the right formula. It is contingent, and radically 
open. While conventional medicine could continue along the same channels—
bioprospecting, bioengineering, developing, testing and marketing—it doesn’t 
have to. Discoveries in postgenomics and microbiomics and the deepening of a 
self-diagnosing internet culture (Julavits 2014), stands ready to change the game. 
The question is, how will we shape our medical future? 
Hookworms may serve as part of an anti-politics machine when they are a 
pathogen to be eradicated (Ferguson 1990), but as a treatment, they bring into 
focus questions about economic disparity, mutual aid, social constructions, the 
value of human health, the instability of the medical expert and biopolitical 
governance. My interviewees questioned all of these factors as they rewrote the 
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rules. They are becoming a new kind of folk experts, and it is in the interest of 
pharmaceutical companies and medical researchers to follow the results of do-it-
yourself treatments. For public health, this may seem a risky strategy, especially 
when dealing with a pathogen. However, as we know, pharmaceutical 
companies regularly take risks when testing new drugs in the US and abroad. 
Do-it-yourself helminthic therapy puts this risk in the direct control of citizens 
rather than pharmaceutical companies—perhaps a boon to patients, but also with 
potentially enormous benefit to pharmaceutical companies. Rather than allowing 
the pharmaceutical companies to profit from the experimentation of citizens, or 
on the other hand, to cut patients off from their desired, untested treatments, 
public health and governmental institutions could begin to provide further 
protections to patients. These protections would not be from the corporate 
development of new drugs, but from the enormous profit margins that 
pharmaceutical companies stand to make from these new drugs without 
recompense to citizens. Patients need these protections in an atmosphere that 
could quickly turn hostile as helminths become a more controlled substance. 
I argue that human and hookworm affect, not a human subjectivity that 
positions humans as primary agents in a mind-over-matter politics, is what could 
be responsible for a turn away from pharmaceuticals and conventional medicine, 
and toward a do-it-yourself movement. Because of the multivalence of 
hookworms, people do not see hookworms solely as companions or charming 
pets. Human subjectivity is forced to break apart because humans—the self-
experimenting humans, in particular—don’t have total control over hookworms. 
As the hookworms pass through skin, they become a part of us, not heroes or 
enemies, but both caring and selfish, giving and fallible. Parasites represent a far 
more challenging break in our monism, one that may challenge us to revisit the 
ways that we live among all other nonhumans. 
A theme that grazed my research somewhat indirectly was the way that 
helminthic therapy is classed. Not only is helminthic therapy generally 
necessitated and practiced in only in developed countries, but also most of the 
patients I interviewed were middle income. Though this could partly be a bias 
from internet selection, it is also, in part, because not everyone can afford to go 
against a doctor’s advice, take time off for an experiment, do hours of internet 
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research, or afford risk their reputation with the stigma of helminths. My 
interviewees, and likely helminth users in general, are a selective group. 
Autoimmune disease is an invisible malady that has often struck wealthier 
people first, perhaps beginning with the fashionable gentleman’s ailment of hay 
fever in the 1800s—can a middle class disease ever be one that breeds radical 
social reforms? Helminthic therapy can be a DIY treatment, which confronts the 
face of capitalist medicine, but it could also become a boutique treatment, in 
which the wealthy get to select the most organic and perfectly evolved helminths 
money can buy. Helminthic therapy could be a new answer to ailments that are 
increasingly affecting the poor more than the rich, or it could become a money 
cow for pharmaceutical companies that outsource their preliminary testing to 
citizens who rely on free message boards for medical advice. The extent to which 
these therapies may exacerbate class difference and health inequalities remains to 
be seen. Yet, taken to their logical conclusion, there’s no way that the 
contingencies within this assemblage don’t open doors of possibility for 
changing the way that we do medicine. It is thus important to continue 
politicizing the debates about bioethics and medicine.  
When I write “politicizing,” however, I don’t mean treading over the same 
political territory we are used to, such as which regulations should be in place, 
which politician is really supporting patients, or who is to blame for the health 
care crisis in the US. Rather, by politics, I mean raising awareness of the agency 
that human and hookworm together create in terms of making concrete, material 
changes in peoples lives.  
While many people are focused on reconstructing our subjectivity in terms of 
our many identities, I argue that material experiences, including ones in which 
humans cannot be categorized by a single identity, paves the way for trumping 
the essentialist, black-and-white modes of thinking and revises concepts of 
unidirectional power—that of human over hookworm or that of industry over 
people. Instead, we are able to show our integral place in those assemblages we 
are not happy with, and using our material experiences with the nonhuman, we 
are able to reterritorialize them together. 
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APPENDIX 
 
Primary questions for patients: 
 
1. Tell me about your medical background. 
2. Tell me about your relationship with doctors. 
3. What did your family think? 
4. Have you always been into alternative medicine? Is HT alternative medicine? 
5. What’s the difference between alternative and conventional medicine? 
6. What do you think about the "yuck" factor? 
7. Briefly, how do you see the worms as working? 
8. How do anecdotes compared to scientific studies? How and in what ways are 
they important?  
9. Would you consider home cultivation? Would you share with a friend if they 
were desperate and couldn’t get the worms overseas? 
10. Any long term solutions for rising autoimmune disease worldwide? 
11. Live worms vs. chemical pill versions: which would you prefer? 
12. Different opinions about patients taking on risk country-to-country, different 
levels of regulation… do you think the FDA should make it easier to access 
untested drugs at the risk of the patient? What is the patient’s role in making 
decisions? How informed can a patient be? 
13. Social media’s importance? 
14. Where do you get your information? How can you trust it? 
 
 
Questions for helminthic therapy researchers and doctors: 
 
1. Is there a role for anecdotes, patient stories, in your work? 
2. When did you shift from studying helminths as harmful to helminths as 
helpful? 
3. Can we duplicate the effects of helminths in a lab? In pill form? 
4. I’ve heard that helminths change according to their hosts…? 
5. Describe what’s happening from the worm’s perspective. 
6. What is an ideal outcome from this research? 
7. Can helminths still be considered parasites, technically? 
8. Do you think that people will ever get over the “yuck” factor? 
9. Do the benefits of HT outweigh the drawbacks? 
10. What is the difference between HT and other treatments? 
11. Is it hard to find funding? 
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